<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur J Pediatr</journal-id><journal-id journal-id-type="iso-abbrev">Eur J Pediatr</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title>European Journal of Pediatrics</journal-title></journal-title-group><issn pub-type="ppub">0340-6199</issn><issn pub-type="epub">1432-1076</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC9056471</article-id><article-id pub-id-type="pmcid-ver">PMC9056471.1</article-id><article-id pub-id-type="pmcaid">9056471</article-id><article-id pub-id-type="pmcaiid">9056471</article-id><article-id pub-id-type="pmid">35175416</article-id><article-id pub-id-type="doi">10.1007/s00431-022-04407-w</article-id><article-id pub-id-type="publisher-id">4407</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Paracetamol (acetaminophen) use in infants and children was never shown to be safe for neurodevelopment: a systematic review with citation tracking</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Cendejas-Hernandez</surname><given-names initials="J">Jasmine</given-names></name><address><email>jasmine.cendejas.hernandez@duke.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sarafian</surname><given-names initials="JT">Joshua T.</given-names></name><address><email>joshua.hames@duke.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Lawton</surname><given-names initials="VG">Victoria G.</given-names></name><address><email>victoria.g.lawton@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Palkar</surname><given-names initials="A">Antara</given-names></name><address><email>antara.palkar@gmail.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Anderson</surname><given-names initials="LG">Lauren G.</given-names></name><address><email>lauren.g.anderson@duke.edu</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Larivi&#232;re</surname><given-names initials="V">Vincent</given-names></name><address><email>vincent.lariviere@umontreal.ca</email></address><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0003-3644-9152</contrib-id><name name-style="western"><surname>Parker</surname><given-names initials="W">William</given-names></name><address><email>William.Parker@WilliamParkerLab.org</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.26009.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7961</institution-id><institution>Department of Surgery, </institution><institution>Duke University School of Medicine, </institution></institution-wrap>Durham, NC USA </aff><aff id="Aff2"><label>2</label>WPLab, Inc, 1023 Wells St, Durham, NC 27707 USA </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.14848.31</institution-id><institution-id institution-id-type="ISNI">0000 0001 2292 3357</institution-id><institution>&#201;cole de Biblioth&#233;conomie Et Des Sciences de L&#8217;information, </institution><institution>Universit&#233; de Montr&#233;al, </institution></institution-wrap>Montreal, Canada </aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.26009.3d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1936 7961</institution-id><institution>Duke Global Health Institute, Duke University and Duke University Medical Center, </institution></institution-wrap>Durham, NC 27710 USA </aff></contrib-group><author-notes><fn fn-type="com"><p>Communicated by Peter de Winter</p></fn></author-notes><pub-date pub-type="epub"><day>17</day><month>2</month><year>2022</year></pub-date><pub-date pub-type="ppub"><year>2022</year></pub-date><volume>181</volume><issue>5</issue><issue-id pub-id-type="pmc-issue-id">406520</issue-id><fpage>1835</fpage><lpage>1857</lpage><history><date date-type="received"><day>23</day><month>11</month><year>2021</year></date><date date-type="rev-recd"><day>28</day><month>1</month><year>2022</year></date><date date-type="accepted"><day>1</day><month>2</month><year>2022</year></date></history><pub-history><event event-type="pmc-release"><date><day>17</day><month>02</month><year>2022</year></date></event><event event-type="pmc-live"><date><day>07</day><month>05</month><year>2022</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2023-09-15 10:25:10.450"><day>15</day><month>09</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2022</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold>This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="431_2022_Article_4407.pdf"/><abstract id="Abs1"><p id="Par1">Although widely believed by pediatricians and parents to be safe for use in infants and children when used as directed, increasing evidence indicates that early life exposure to paracetamol (acetaminophen) may cause long-term neurodevelopmental problems. Furthermore, recent studies in animal models demonstrate that cognitive development is exquisitely sensitive to paracetamol exposure during early development. In this study, evidence for the claim that paracetamol is safe was evaluated using a systematic literature search. Publications on PubMed between 1974 and 2017 that contained the keywords &#8220;infant&#8221; and either &#8220;paracetamol&#8221; or &#8220;acetaminophen&#8221; were considered. Of those initial 3096 papers, 218 were identified that made claims that paracetamol was safe for use with infants or children. From these 218, a total of 103 papers were identified as sources of authority for the safety claim.</p><p id="Par2"><italic toggle="yes">&#160; &#160;Conclusion</italic>: A total of 52 papers contained actual experiments designed to test safety, and had a median follow-up time of 48&#160;h. None monitored neurodevelopment. Furthermore, no trial considered total exposure to drug since birth, eliminating the possibility that the effects of drug exposure on long-term neurodevelopment could be accurately assessed. On the other hand, abundant and sufficient evidence was found to conclude that paracetamol does not induce acute liver damage in babies or children when used as directed.
<table-wrap id="Taba" position="float" orientation="portrait"><table frame="hsides" rules="groups"><tbody><tr><td colspan="2" rowspan="1"><p><bold>What is Known:</bold></p><p><italic toggle="yes">&#8226; Paracetamol (acetaminophen) is widely thought by pediatricians and parents to be safe when used as directed in the pediatric population, and is the most widely used drug in that population, with more than 90% of children exposed to the drug in some reports.</italic></p><p><italic toggle="yes">&#8226; Paracetamol is known to cause liver damage in adults under conditions of oxidative stress or when used in excess, but increasing evidence from studies in humans and in laboratory animals indicates that the target organ for paracetamol toxicity during early development is the brain, not the liver.</italic></p></td></tr><tr><td colspan="2" rowspan="1"><p><bold>What is New:</bold></p><p><italic toggle="yes">&#8226; This study finds hundreds of published reports in the medical literature asserting that paracetamol is safe when used as directed, providing a foundation for the widespread belief that the drug is safe.</italic></p><p><italic toggle="yes">&#8226; This study shows that paracetamol was proven to be safe by approximately 50 short-term studies demonstrating the drug&#8217;s safety for the pediatric liver, but the drug was never shown to be safe for neurodevelopment.</italic></p></td></tr></tbody></table></table-wrap></p><sec><title>Graphical abstract</title><p id="Par3">Paracetamol is widely believed to be safe for infants and children when used as directed, despite mounting evidence in humans and in laboratory animals indicating that the drug is not safe for neurodevelopment. An exhaustive search of published work cited for safe use of paracetamol in the pediatric population revealed 52 experimental studies pointing toward safety, but the median follow-up time was only 48&#160;h, and neurodevelopment was never assessed.</p><p id="Par4">
<graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="MO1" orientation="portrait" xlink:href="431_2022_4407_Figa_HTML.jpg"/></p></sec><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1007/s00431-022-04407-w.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Behavior</kwd><kwd>Neurodevelopment</kwd><kwd>Infant</kwd><kwd>Child</kwd><kwd>Autism</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer-Verlag GmbH Germany, part of Springer Nature 2022</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Background</title><p id="Par16">Most parents and pediatricians currently believe that use of paracetamol in infants and children is safe, promulgating widespread use of the drug in that population. Use of paracetamol in the pediatric populations now exceeds 90% in some studies [<xref ref-type="bibr" rid="CR1">1</xref>] and persists even under circumstances in which the drug may have no benefits, such as prophylaxis prior to some vaccinations [<xref ref-type="bibr" rid="CR2">2</xref>] and treatment of mild fevers [<xref ref-type="bibr" rid="CR3">3</xref>]. Such beliefs and practices are strengthened and supported by a medical literature which repeatedly asserts without reservation that, when used as directed, the drug is safe in the pediatric population. However, mounting evidence points toward the view that paracetamol exposure during early development can have an adverse effect on neurodevelopment, even when used as directed. For example, in a recent review [<xref ref-type="bibr" rid="CR4">4</xref>], eight studies supporting a link between prenatal paracetamol exposure and neurodevelopmental problems were identified [<xref ref-type="bibr" rid="CR5">5</xref>&#8211;<xref ref-type="bibr" rid="CR12">12</xref>]. In the 3&#160;years since that review, at least six additional studies have confirmed this same relationship, three of which have used data from the Norwegian Mother and Child Cohort Study [<xref ref-type="bibr" rid="CR13">13</xref>&#8211;<xref ref-type="bibr" rid="CR18">18</xref>]. Although exposure to paracetamol in utero is associated with neurodevelopmental problems, even after consideration of potentially confounding factors, the effects are typically small, and the amount of paracetamol required to yield the effect is greater than the amount typically used by average individuals. For example, after adjusting for potential confounders such as parental education level, use of vitamin supplements, parental BMI, smoking, and use of other drugs, Skovlund and colleagues found a weak yet significant association between prenatal exposure to paracetamol and mother-reported communication skills: the chances of being in a lower development category increased with increasing periods of prenatal paracetamol use but not prenatal opioid use [<xref ref-type="bibr" rid="CR13">13</xref>]. In another example, using propensity score matching, Vlenterie and colleagues found that 28 or more days of paracetamol use during pregnancy was associated with a modestly increased risk of delayed motor milestone attainment (OR: 1.35, 95% CI 1.07&#8211;1.70) by children at 18&#160;months [<xref ref-type="bibr" rid="CR14">14</xref>]. </p><p id="Par17">Evidence points toward a higher risk of paracetamol-induced neurodevelopmental disorders when exposure occurs after birth as compared to in utero. Studies using laboratory rodents demonstrate that exposure to near therapeutic doses of paracetamol during the first days of life induces profound, long-term neurological changes [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>], whereas somewhat higher doses are required to induce permanent neurological damage during pregnancy [<xref ref-type="bibr" rid="CR21">21</xref>]. These laboratory studies demonstrate that the target organ for toxicity in neonates is the central nervous system, not the liver, and demonstrate that if paracetamol had been tested using current guidelines, it would never have been approved for use in children. More concerning are observations in children indicating that paracetamol is not safe for neurodevelopment. The 2008 study which first raised a red flag regarding the safety of paracetamol during neurodevelopment found a greater than 20-fold risk of regressive autism with paracetamol use during childhood [<xref ref-type="bibr" rid="CR22">22</xref>]. Although this relatively small study did not attract enough interest to promote larger studies, other lines of evidence support the view that paracetamol exposure during early life can lead to neurodevelopmental disorders. For example, a startling twofold greater incidence of infantile autism in circumcised boys compared to non-circumcised boys [<xref ref-type="bibr" rid="CR23">23</xref>] can be readily explained by potentially negative impacts of paracetamol exposure during and following the circumcision procedure [<xref ref-type="bibr" rid="CR4">4</xref>]. Sadly, the widely held and entrenched belief that vaccines induce autism [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>] may be yet another result of the impact of paracetamol on neurodevelopment in combination with widespread use of the drug during vaccination [<xref ref-type="bibr" rid="CR4">4</xref>].</p><p id="Par18">With the above concerns in mind, a systematic evaluation of the peer-reviewed literature was initiated to address the question of why paracetamol is widely believed to be safe for use during early development. All papers published between 1974 and 2017 that contained the keywords &#8220;infant&#8221; and either &#8220;paracetamol&#8221; or &#8220;acetaminophen&#8221; were considered. All papers which made claims that paracetamol or acetaminophen is safe for use in infants or children were identified, and the justification for this claim was critically evaluated.</p><p id="Par19">The use of paracetamol predates current safety standards used in the pharmaceutical industry, and even if current standards were applied, those standards do not mandate testing for long-term neurological development. Thus, to those aware of the inner workings of the drug approval process, especially as it has been applied to paracetamol, the results obtained in this study will not be surprising and may even be considered by some to be a foregone conclusion that need not be evaluated. Nevertheless, the widespread belief that paracetamol is safe and the resulting widespread use of the drug in the pediatric population is built on the assumption that it is safe for neurodevelopment. With this in mind, this review focuses on unqualified claims of safety in the medical literature that, reasonably, are taken by parents and even many physicians to indicate that the drug is safe for neurodevelopment.</p></sec><sec id="Sec2"><title>Methods</title><p id="Par20">As a first step in understanding why paracetamol is thought to be safe during early development, all titles and abstracts in the PubMed<sup>&#174;</sup> Database with keywords &#8220;infant&#8221; and &#8220;acetaminophen or paracetamol&#8221; published between 1974 and 2017 were identified. The term &#8220;infant&#8221; rather than &#8220;child&#8221; was selected because (a) the number of papers with the term &#8220;child&#8221; was prohibitively large, and (b) the focus of the study was intended to be on drug exposure during early development, from birth to age approximately 6&#160;years, not individuals up to the age of 17&#160;years. In all cases, the terms paracetamol and acetaminophen were taken to be synonymous, and no distinctions were made.</p><p id="Par21">In the second step, two coauthors (JCH and JTS) independently screened all titles and abstracts. In this step, articles that could not be obtained in English and all articles not describing use of paracetamol in humans were eliminated from the study. Based on titles and abstracts (if available), articles were tagged which were deemed likely to make claims regarding the safety of paracetamol use in infants and children between birth and age 6&#160;years.</p><p id="Par22">In the third step, two coauthors (JCH and JTS), continuing to work independently, examined full texts of all tagged titles and abstracts. Texts were examined for the following three assertions:</p><p id="Par23">
<list list-type="alpha-lower"><list-item><p id="Par24">Paracetamol use is &#8220;safe&#8221; in children or infants.</p></list-item><list-item><p id="Par25">Paracetamol is the &#8220;drug of choice&#8221; in children or infants.</p></list-item><list-item><p id="Par26">Paracetamol use is &#8220;recommended&#8221; for children or infants.</p></list-item></list>
</p><p id="Par27">In cases where the terms &#8220;drug of choice&#8221; or &#8220;recommended&#8221; were used, the context was considered. In some cases, particularly in manuscripts expressing caution regarding the use of paracetamol, these terms were not taken to imply safety, but rather were taken to be an indicator of the common acceptance of the drug. These articles were excluded from the study. Based on this approach, articles were tagged that were considered to have made safely claims regarding the use of paracetamol in infants or children younger than 6&#160;years old.</p><p id="Par28">Still working independently, two coauthors (JCH and JTS) evaluated each manuscript making a claim of safety, determining the source of authority for the stated claim. If no literature was cited to support the claim, this was documented. In cases where the source that was cited contained another citation, that secondary reference was obtained and evaluated. This process continued as needed until an original source or sources describing an actual demonstration of safety was identified. An example of the results of this process is shown in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Flow diagram illustrating connections between articles claiming that paracetamol use is safe for infants or children when used as directed. In this example, the citations in a paper by Temple and colleagues in 2017 [<xref ref-type="bibr" rid="CR30">30</xref>] are assessed. Articles describing new experiments designed to test safety of paracetamol or which contain claims of safety without citation are included in Table <xref rid="Tab2" ref-type="table">2</xref> and are indicated by a check mark. Articles shown in the diagram which do not describe experiments designed to test safety of paracetamol and which cite other articles as a source for claims of safety [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR159">159</xref>] are not included in Table <xref rid="Tab2" ref-type="table">2</xref> and are not indicted by a check in the diagram</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="431_2022_4407_Fig1_HTML.jpg"/></fig></p><p id="Par29">In the fourth step, any discrepancies between the analyses provided by coauthors JCH and JTS were arbitrated by coauthor WP. In the fifth step, articles upon which safety claims were based were compiled. Finally, articles which made safety claims and articles upon which safety claims were based were evaluated for actual experiments designed to assess safety. For each experiment described, the study group, endpoints measured, and follow-up time were evaluated. Data were graphed and descriptive statistics calculated using GraphPad Prism 8 software. The review was not registered, and the protocol is as described in this Methods section.</p></sec><sec id="Sec3"><title>Results</title><p id="Par30">An overview of results from a systematic search for studies demonstrating safety of paracetamol use in infants and children is shown in Table <xref rid="Tab1" ref-type="table">1</xref>. The initial Medline search provided 3096 articles that contained the terms infant and either paracetamol or acetaminophen that were published between 1974 and 2017. From these articles, 467 were selected for assessment based on likelihood of safety claims regarding use of paracetamol in infants or children. Of these 467 articles, 218 made safety claims regarding the use of paracetamol in infants or children. During this phase of the study, numerous articles were identified which either claimed or demonstrated that paracetamol use, even at doses beyond the recommended dose, does not generally cause long-term liver damage in infants or children. Any claims of safety for liver function were not evaluated in detail and were not considered in this study. Only general claims of safety were assessed.<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Number of citations identified in the systematic search during each step of the study. Numbers are provided for both analysts performing the work (JCH and JTS). The overlap is the number of citations that were the same between the two analysts</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Step</th><th align="left" colspan="1" rowspan="1">JCH</th><th align="left" colspan="1" rowspan="1">Overlap</th><th align="left" colspan="1" rowspan="1">JTS</th><th align="left" colspan="1" rowspan="1">Total</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">1. Medline (paracetamol&#8201;+&#8201;infant)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">3096</td></tr><tr><td align="left" colspan="1" rowspan="1">2. Safety claim, first step</td><td align="left" colspan="1" rowspan="1">310</td><td align="left" colspan="1" rowspan="1">193</td><td align="left" colspan="1" rowspan="1">350</td><td align="left" colspan="1" rowspan="1">467</td></tr><tr><td align="left" colspan="1" rowspan="1">3. Safety claim, second step</td><td align="left" colspan="1" rowspan="1">189</td><td align="left" colspan="1" rowspan="1">144 (53*)</td><td align="left" colspan="1" rowspan="1">189</td><td align="left" colspan="1" rowspan="1">234</td></tr><tr><td align="left" colspan="1" rowspan="1">4. Safety claim, final</td><td align="left" colspan="1" rowspan="1">173</td><td align="left" colspan="1" rowspan="1">128 (37*)</td><td align="left" colspan="1" rowspan="1">173</td><td align="left" colspan="1" rowspan="1">218</td></tr><tr><td align="left" colspan="1" rowspan="1">5. Sources attributed to safety claim</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">103</td></tr><tr><td align="left" colspan="1" rowspan="1">6A. Sources with experiments supporting safety claim</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">36</td></tr><tr><td align="left" colspan="1" rowspan="1">6B. Safety claim, not cited as a source, with experiments supporting safety claim</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">16</td></tr></tbody></table><table-wrap-foot><p>*Numbers in parentheses indicated the number of citations in which both analysts identified the same citation, but not the same source or sources as the authority for claims of safety.</p></table-wrap-foot></table-wrap></p><p id="Par31">Of the 218 articles making claims that paracetamol use in infants or children is safe, half (114) provided no citation. The other half (114) of the articles cited additional articles as evidence that paracetamol is safe in infants or children. Articles making safety claims as well as articles cited as sources of authority for safety claims were evaluated as described in the Methods. In some cases, the &#8220;primary&#8221; cited articles did not make original claims of safety, but rather cited additional (&#8220;secondary&#8221;) articles. In cases where a primary article cited another article, the primary article was not considered to have made an original claim of safety, and was not evaluated further. An example of the results of this process is shown in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>. Both primary articles and secondary (and tertiary, etc.) articles attributed with claims of the safety of paracetamol use in infants or children were compiled and are shown in Table <xref rid="Tab2" ref-type="table">2</xref>. In total, 103 articles were identified which were cited as containing original claims that paracetamol use in infants or children is safe when used as directed. In addition, 16 of the 218 articles with safety claims (a) made those claims based on original experimental evidence and (b) were not cited by other papers. These articles are also included in Table <xref rid="Tab2" ref-type="table">2</xref>, listed at the bottom of the table with zero citations.<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Sources of authority for the assertion that paracetamol is safe for infants or children when used as directed</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"><bold>Sources cited for safety of paracetamol in children or infants: study number, year, and design</bold></th><th align="left" colspan="1" rowspan="1"><bold>Study subjects</bold></th><th align="left" colspan="1" rowspan="1"><bold>Outcome measures related to safety or safety claims made</bold></th><th align="left" colspan="1" rowspan="1"><bold>Duration of monitoring</bold></th><th align="left" colspan="1" rowspan="1"><bold>Times cited</bold></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">1. 1999: Double-blind clinical trial with three treatments, one of paracetamol and two different concentrations of ibuprofen given for fever [<xref ref-type="bibr" rid="CR26">26</xref>]</td><td align="left" colspan="1" rowspan="1">9127 children treated with paracetamol; median age is 14&#160;months</td><td align="left" colspan="1" rowspan="1">&#8220;Serious adverse clinical events&#8221; requiring hospitalization: gastrointestinal bleeding, renal failure, anaphylaxis, Reye&#8217;s syndrome, asthma, bronchiolitis, and vomiting/gastritis</td><td align="left" colspan="1" rowspan="1">4&#160;weeks</td><td align="left" colspan="1" rowspan="1">13</td></tr><tr><td align="left" colspan="1" rowspan="1">2. 1997: Randomized, double-blind, three-way crossover study with three treatments, one each of paracetamol, ibuprofen, and placebo given by parents for headache. Each child with three migraine attacks was treated in random order with single oral doses of the study drugs [<xref ref-type="bibr" rid="CR44">44</xref>]</td><td align="left" colspan="1" rowspan="1">80 children were treated with paracetamol, age range approximately 4 to 16&#160;years</td><td align="left" colspan="1" rowspan="1">Monitoring by parents for &#8220;adverse events&#8221;: nausea, vomiting, and gastric pain</td><td align="left" colspan="1" rowspan="1">2&#160;h: all patients received paracetamol at some point, so long-term monitoring was not feasible</td><td align="left" colspan="1" rowspan="1">9</td></tr><tr><td align="left" colspan="1" rowspan="1">3. 1978: Editorial describing current practice with analgesic use in children [<xref ref-type="bibr" rid="CR45">45</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Editorial</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;anticipated liver damage is not observed&#8221; based on personal experience and interactions with other clinicians</td><td align="left" colspan="1" rowspan="1">NA: Editorial</td><td align="left" colspan="1" rowspan="1">8</td></tr><tr><td align="left" colspan="1" rowspan="1">4. 2001: Review describing analgesic use in children [<xref ref-type="bibr" rid="CR46">46</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;40-year safety record in children&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">8</td></tr><tr><td align="left" colspan="1" rowspan="1">5. 1978: Review describing antipyretic therapy in febrile children [<xref ref-type="bibr" rid="CR47">47</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;relatively free of adverse reactions&#8221; without citation and 9 citations provided for the statement that hepatotoxicity from paracetamol in children is &#8220;very low compared with that seen in adults.&#8221;</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">7</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>6. 2000: Renn, 2000</p><p>Erroneous citation*</p></td><td align="left" colspan="1" rowspan="1">NA: Erroneous citation</td><td align="left" colspan="1" rowspan="1">NA: Erroneous citation</td><td align="left" colspan="1" rowspan="1">NA: Erroneous citation</td><td align="left" colspan="1" rowspan="1">7</td></tr><tr><td align="left" colspan="1" rowspan="1">7. 2011: Report describing current recommended practice [<xref ref-type="bibr" rid="CR48">48</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Report</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;generally regarded as safe&#8221; without citation. Lesko (1999) is cited for equivalent safety between ibuprofen and paracetamol</td><td align="left" colspan="1" rowspan="1">NA: Report</td><td align="left" colspan="1" rowspan="1">7</td></tr><tr><td align="left" colspan="1" rowspan="1">8. 1983: Review describing pediatric dosing of paracetamol [<xref ref-type="bibr" rid="CR49">49</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;one of the safest&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">6</td></tr><tr><td align="left" colspan="1" rowspan="1">9. 1995: Double-blind clinical trial with three treatments, one of paracetamol and two of different concentrations ibuprofen given for fever [<xref ref-type="bibr" rid="CR50">50</xref>]</td><td align="left" colspan="1" rowspan="1">28,130 children treated with paracetamol; median age is 40&#160;months</td><td align="left" colspan="1" rowspan="1">Serious events defined as hospitalization for acute gastrointestinal bleeding, acute renal failure, or anaphylaxis</td><td align="left" colspan="1" rowspan="1">4&#160;weeks</td><td align="left" colspan="1" rowspan="1">6</td></tr><tr><td align="left" colspan="1" rowspan="1">10. 1998: Practice guidelines** [<xref ref-type="bibr" rid="CR51">51</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Practice guidelines</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;As demonstrated by the numerous prospective clinical studies,&#8221; paracetamol is &#8220;remarkably safe in therapeutic doses,&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Practice guidelines</td><td align="left" colspan="1" rowspan="1">5</td></tr><tr><td align="left" colspan="1" rowspan="1">11. 1972: Double-blind study with two treatments, one each of aspirin and paracetamol, given for antipyretic effect [<xref ref-type="bibr" rid="CR34">34</xref>]</td><td align="left" colspan="1" rowspan="1">39 children treated with paracetamol, age 6&#160;months to 6&#160;years</td><td align="left" colspan="1" rowspan="1">Unspecified &#8220;complications or side effects.&#8221;</td><td align="left" colspan="1" rowspan="1">6&#160;h</td><td align="left" colspan="1" rowspan="1">5</td></tr><tr><td align="left" colspan="1" rowspan="1">12. 1977: Clinical guidelines for use, predominantly focused on aspirin, but also including paracetamol. [<xref ref-type="bibr" rid="CR33">33</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Clinical guidelines</td><td align="left" colspan="1" rowspan="1">Considered to have a &#8220;wide range of safety&#8221; based on &#8220;the large doses of paracetamol required to evoke toxic reactions&#8221; in laboratory animals. In addition, considered &#8220;safe and effective when used as directed,&#8221; with two studies cited [<xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR35">35</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Clinical guidelines</td><td align="left" colspan="1" rowspan="1">4</td></tr><tr><td align="left" colspan="1" rowspan="1">13. 1978: Commentary on paracetamol use [<xref ref-type="bibr" rid="CR52">52</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Commentary</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;safe and effective analgesic and antipyretic in usual therapeutic dosage&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Commentary</td><td align="left" colspan="1" rowspan="1">4</td></tr><tr><td align="left" colspan="1" rowspan="1">14. 1978: Review comparing aspirin&#8217;s and paracetamol&#8217;s antipyretic and analgesic activity [<xref ref-type="bibr" rid="CR53">53</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;the choice of agents for antipyresis in clinical practice has been narrowed to aspirin and paracetamol&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">4</td></tr><tr><td align="left" colspan="1" rowspan="1">15. 1996: Review of paracetamol liver toxicity in children under the age of 6&#160;years [<xref ref-type="bibr" rid="CR54">54</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Makes no general safety claim, although extensive references are provided showing that paracetamol does not cause long-term damages to infants&#8217; livers</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">4</td></tr><tr><td align="left" colspan="1" rowspan="1">16. 1997: Double-blind clinical trial with three treatments, one of paracetamol and two different concentrations of ibuprofen given for fever [<xref ref-type="bibr" rid="CR55">55</xref>]</td><td align="left" colspan="1" rowspan="1">97 children treated with paracetamol; median age is 29&#160;months</td><td align="left" colspan="1" rowspan="1">Renal function as indicated by blood urea nitrogen (BUN) and creatinine levels</td><td align="left" colspan="1" rowspan="1">4&#160;weeks</td><td align="left" colspan="1" rowspan="1">4</td></tr><tr><td align="left" colspan="1" rowspan="1">17. 1972: Clinical study with three treatments, one each of aspirin, paracetamol, and a combination of the two given for fever [<xref ref-type="bibr" rid="CR35">35</xref>]</td><td align="left" colspan="1" rowspan="1">80 children treated with paracetamol, age 6&#160;months to 5&#160;years</td><td align="left" colspan="1" rowspan="1">No outcome measures specified</td><td align="left" colspan="1" rowspan="1">6&#160;h or less</td><td align="left" colspan="1" rowspan="1">4</td></tr><tr><td align="left" colspan="1" rowspan="1">18. 2005: Pharmacokinetic study. [<xref ref-type="bibr" rid="CR56">56</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Pharmacokinetic study</td><td align="left" colspan="1" rowspan="1">No safety outcomes reported. No safety claims made</td><td align="left" colspan="1" rowspan="1">NA: Pharmacokinetic study</td><td align="left" colspan="1" rowspan="1">3</td></tr><tr><td align="left" colspan="1" rowspan="1">19. 2011: Randomized open-label study with two dosing regimens of intravenous paracetamol given for analgesic or antipyretic effect. [<xref ref-type="bibr" rid="CR57">57</xref>] Intravenous paracetamol contains cysteine, an antidote for paracetamol poisoning. The antidote is not present in the oral medication</td><td align="left" colspan="1" rowspan="1">75 patients total were treated with paracetamol, 3 neonates, 25 infants, 25 children, and 22 adolescents</td><td align="left" colspan="1" rowspan="1">Changes in liver enzymes, changes in vital signs, and reported or observed adverse drug effects, which included the following: anemia, constipation, nausea, vomiting, face edema, pyrexia, hypokalemia, hypomagnesemia, hypophosphatemia, agitation, atelectasis, pleural effusion, pulmonary edema, stridor, wheezing, periorbital edema, and pruritus</td><td align="left" colspan="1" rowspan="1">48&#160;h</td><td align="left" colspan="1" rowspan="1">3</td></tr><tr><td align="left" colspan="1" rowspan="1">20. 1973: Review describing precautions with paracetamol use [<xref ref-type="bibr" rid="CR58">58</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Makes no safety claim with respect to pediatric use</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">21. 1981: Review comparing efficacy of aspirin and paracetamol in fever reduction in children [<xref ref-type="bibr" rid="CR59">59</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: a &#8220;high degree of safety&#8221; at therapeutic doses without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">22. 1992: Pharmacokinetic study in adults aged 21&#8211;25&#160;years [<xref ref-type="bibr" rid="CR60">60</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Pharmacokinetic study</td><td align="left" colspan="1" rowspan="1">NA: study in adults</td><td align="left" colspan="1" rowspan="1">NA: Pharmacokinetic study</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">23. 1993: Review [<xref ref-type="bibr" rid="CR61">61</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;Recent data have supported the relative safety (and efficiency) of paracetamol in newborn infants&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">24. 1996: Double-blind study with two treatments, one of each ibuprofen and paracetamol, given for fever [<xref ref-type="bibr" rid="CR62">62</xref>]</td><td align="left" colspan="1" rowspan="1">47 children were treated with paracetamol, age 0.2 to 9.4&#160;years; median age is 1.6&#160;years</td><td align="left" colspan="1" rowspan="1">Extensive assessment of adverse events. Claims: &#8220;majority of adverse events had a doubtful or no relationship the treatment, and most were considered mild.&#8221;</td><td align="left" colspan="1" rowspan="1">36&#160;h</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">25. 1997: Computer simulation used to predict dosing needed to achieve desired concentration of drug in plasma [<xref ref-type="bibr" rid="CR63">63</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Computer simulation</td><td align="left" colspan="1" rowspan="1">No safety claims made</td><td align="left" colspan="1" rowspan="1">NA: Computer simulation</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">26. 1997: Pharmacokinetic study [<xref ref-type="bibr" rid="CR64">64</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Pharmacokinetic study</td><td align="left" colspan="1" rowspan="1">No safety outcomes reported. Claims: &#8220;Commonly used in children because of its (efficacy and) safety&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Pharmacokinetic study</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">27. 1999: Pharmacokinetic study with a single rectal dose of paracetamol [<xref ref-type="bibr" rid="CR65">65</xref>]</td><td align="left" colspan="1" rowspan="1">28 preterm neonates, 2&#160;days after birth</td><td align="left" colspan="1" rowspan="1">No safety outcomes stated. Claimed: &#8220;safe&#8221;</td><td align="left" colspan="1" rowspan="1">Up to 12&#160;h</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">28. 2007: Comparison of efficacy between paracetamol and ibuprofen. First phase was a single dose, double-blind administered in the clinic, followed by an open-label phase administered at home for the second and subsequent doses. [<xref ref-type="bibr" rid="CR66">66</xref>]</td><td align="left" colspan="1" rowspan="1">150 patients treated with paracetamol, age range approximately 0.40 to 11&#160;years; average age is 3.71&#160;years</td><td align="left" colspan="1" rowspan="1">Monitoring for &#8220;adverse events,&#8221; three of which were infections, gastrointestinal disorders, and respiratory disorders</td><td align="left" colspan="1" rowspan="1">3&#160;days</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">29. 2008: Retrospective study using data collected in neonates treated with intravenous paracetamol. [<xref ref-type="bibr" rid="CR67">67</xref>]</td><td align="left" colspan="1" rowspan="1">149 neonates total, median postmenstrual age 38&#160;weeks and median postnatal age is 5&#160;days</td><td align="left" colspan="1" rowspan="1">Hepatic enzyme profiles including ALT, AST, and GGT</td><td align="left" colspan="1" rowspan="1">48&#160;h</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">30. 2011: Review describing NSAIDs and paracetamol and their roles in reducing side-effects after surgery [<xref ref-type="bibr" rid="CR68">68</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Makes no safety claim</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">31. 2013: Review describing dosing and antipyretic efficacy of paracetamol [<xref ref-type="bibr" rid="CR69">69</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;dosing range is well tolerated in children&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">32. 1965. Pharmacology reference book [<xref ref-type="bibr" rid="CR70">70</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Pediatric dose stated without citation, and without further discussion of pediatric use. Makes no safety claim</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">33. 1967: Clinical comparison of a single dose of paracetamol, aspirin, and salicylamide [<xref ref-type="bibr" rid="CR71">71</xref>]</td><td align="left" colspan="1" rowspan="1">50 infants treated with paracetamol, up to 48&#160;months old</td><td align="left" colspan="1" rowspan="1">Unspecified &#8220;undesirable effects&#8221; not observed</td><td align="left" colspan="1" rowspan="1">6&#160;h</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">34. 1978: Review describing the pathophysiology of aspirin overdosage [<xref ref-type="bibr" rid="CR72">72</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Does not discuss paracetamol. Makes no safety claims</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">35: 1982. Monitoring of drug use by the Pediatric Drug Surveillance Program [<xref ref-type="bibr" rid="CR73">73</xref>]</td><td align="left" colspan="1" rowspan="1">1158 children, up to age 16, received paracetamol</td><td align="left" colspan="1" rowspan="1">Adverse events not reported. Makes no safety claim</td><td align="left" colspan="1" rowspan="1">NA: No follow-up conducted</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">36. 1982: An abstract [<xref ref-type="bibr" rid="CR74">74</xref>] cited by Ragg, 1997 [<xref ref-type="bibr" rid="CR75">75</xref>]</td><td align="left" colspan="1" rowspan="1">Not determined</td><td align="left" colspan="1" rowspan="1">Not determined</td><td align="left" colspan="1" rowspan="1">Not determined</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">37. 1984: Prospective study observing adverse drug reactions in pediatric inpatients. [<xref ref-type="bibr" rid="CR76">76</xref>]</td><td align="left" colspan="1" rowspan="1">132 children, age not specified, received an antipyretic or analgesics while hospitalized (paracetamol not mentioned)</td><td align="left" colspan="1" rowspan="1">No side effects observed. No safety claims made</td><td align="left" colspan="1" rowspan="1">During inpatient stay: time not specified</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">38. 1989: Editorial comparing ibuprofen and paracetamol [<xref ref-type="bibr" rid="CR77">77</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Editorial</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;therapeutic doses of either drug [ibuprofen and paracetamol] cause no discernable adverse effects&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Editorial</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">39. 1989: Review assessing pain in neonates and the approaches to postoperative analgesia [<xref ref-type="bibr" rid="CR78">78</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;Recent data have supported the relative safety and analgesic efficacy of paracetamol in newborn infants&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">40. 1990: Pharmacology reference book [<xref ref-type="bibr" rid="CR79">79</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;usually well tolerated&#8221; without citation, but use in pediatric populations is not discussed</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">41. 1991: Review describing paracetamol hepatotoxicity and poisoning in children [<xref ref-type="bibr" rid="CR80">80</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Makes no safety claim</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">42. 1992: Review describing the hepatotoxicity of non-steroidal anti-inflammatory drugs [<xref ref-type="bibr" rid="CR81">81</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: paracetamol is &#8220;normally very safe when used properly&#8221; although this statement does not necessarily refer to pediatric use</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">43. 1992: Randomized, double-blind, multidose, parallel-group, variable duration clinical trial with three different concentrations of ibuprofen and one of paracetamol given for pediatric fever [<xref ref-type="bibr" rid="CR82">82</xref>]</td><td align="left" colspan="1" rowspan="1">16 children treated with paracetamol; average age is 5.2&#160;years</td><td align="left" colspan="1" rowspan="1">Adverse events included headache, gastrointestinal effects, sweating, hypothermia, abdominal pain, agitation, nervousness, and adverse experiences related to the respiratory system</td><td align="left" colspan="1" rowspan="1">24 to 48&#160;h</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">44. 1994: Textbook [<xref ref-type="bibr" rid="CR83">83</xref>] cited by Wilson, 1995. [<xref ref-type="bibr" rid="CR84">84</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Textbook</td><td align="left" colspan="1" rowspan="1">Not determined</td><td align="left" colspan="1" rowspan="1">NA: Textbook</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">45. 1996: Double-blind study with two treatments, paracetamol and placebo given for postoperative pain [<xref ref-type="bibr" rid="CR85">85</xref>]</td><td align="left" colspan="1" rowspan="1">100 children were treated with paracetamol, age 3 to 14&#160;years</td><td align="left" colspan="1" rowspan="1">Liver enzymes determined by blood samples</td><td align="left" colspan="1" rowspan="1">24&#160;h</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">46. 1996: Randomized study with two treatment groups, one of which received paracetamol preoperatively and the other postoperatively [<xref ref-type="bibr" rid="CR86">86</xref>]</td><td align="left" colspan="1" rowspan="1">28 children, age 2 to 8&#160;years</td><td align="left" colspan="1" rowspan="1">Outcome measures included pain scores and the need for rescue analgesics</td><td align="left" colspan="1" rowspan="1">240&#160;min</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">47. 1997: Double-blind, multicenter study with two treatments, one each of ibuprofen and paracetamol, given for fever [<xref ref-type="bibr" rid="CR87">87</xref>]</td><td align="left" colspan="1" rowspan="1">56 children treated with paracetamol, age 8&#160;months to 11&#160;years; average age is 4.2&#160;years</td><td align="left" colspan="1" rowspan="1">Changes in temperature. Only side effect reported was vomiting</td><td align="left" colspan="1" rowspan="1">6&#160;h</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">48. 1999: Randomized, double-blind, placebo-controlled study with four different concentrations of paracetamol given after induction of anesthesia [<xref ref-type="bibr" rid="CR88">88</xref>]</td><td align="left" colspan="1" rowspan="1">90 children treated with paracetamol, age 1 to 7&#160;years</td><td align="left" colspan="1" rowspan="1">Postoperative pain was evaluated by behavioral assessment and physiologic measurement. Only side effects reported were postoperative nausea and vomiting</td><td align="left" colspan="1" rowspan="1">24&#160;h</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">49. 1999: Clinical trial examining the efficacy and pharmacokinetics of paracetamol in term infants (multiple-dose) [<xref ref-type="bibr" rid="CR89">89</xref>]</td><td align="left" colspan="1" rowspan="1">10 infants, up to the age of 2&#160;days</td><td align="left" colspan="1" rowspan="1">Adverse events not reported. Claims: &#8220;paracetamol can be administered safely to neonates on the first day of life.&#8221;</td><td align="left" colspan="1" rowspan="1">First 2&#160;days after birth</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">50. 2000: Review describing non-opioid drugs for treatment of postoperative pain [<xref ref-type="bibr" rid="CR90">90</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: rectal paracetamol &#8220;seems safe in children&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">51. 2000: Pharmacokinetic study of postoperative, repeated dosing of rectal paracetamol [<xref ref-type="bibr" rid="CR91">91</xref>]</td><td align="left" colspan="1" rowspan="1">21 children, age 9&#160;weeks to 11&#160;years</td><td align="left" colspan="1" rowspan="1">No sign of adverse effects observed. Claims: &#8220;paracetamol has gained wide acceptance as a simple and safe antipyretic and analgesic in children,&#8221; without citation</td><td align="left" colspan="1" rowspan="1">Variable, from 1 to 5&#160;days</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">52. 2000: Observational study of calls to a poison center to evaluate pediatric paracetamol exposures [<xref ref-type="bibr" rid="CR92">92</xref>]</td><td align="left" colspan="1" rowspan="1">1019 children up to the age of 7&#160;years</td><td align="left" colspan="1" rowspan="1">Parent&#8217;s report of signs of hepatotoxicity</td><td align="left" colspan="1" rowspan="1">72&#160;h</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">53. 2000: Review of paracetamol&#8217;s history, present, and future [<xref ref-type="bibr" rid="CR93">93</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: paracetamol is an &#8220;effective and remarkably safe drug when used properly&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">54. 2000: Randomized, double-blind study with two treatments, one each of diclofenac and paracetamol for postoperative analgesia [<xref ref-type="bibr" rid="CR94">94</xref>]</td><td align="left" colspan="1" rowspan="1">24 children treated with paracetamol, age 5 to 15&#160;years; median age is 10&#160;years</td><td align="left" colspan="1" rowspan="1">Outcome measures used were pain scores and relief of pain or dysphagia. Only side effects reported were nausea and vomiting</td><td align="left" colspan="1" rowspan="1">3&#160;days</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">55. 2000: Integrated Management of Childhood Illness handbook by the World Health Organization [<xref ref-type="bibr" rid="CR95">95</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Makes no safety claims</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">56. 2000: Randomized, double-blind, multicenter study comparing paracetamol controlled-release sprinkles and paracetamol immediate-release elixir in febrile children [<xref ref-type="bibr" rid="CR96">96</xref>]</td><td align="left" colspan="1" rowspan="1">120 patients, age 2 to 11&#160;years</td><td align="left" colspan="1" rowspan="1"><p>Disorientation, extreme irritability, and confusion were the only adverse events recorded</p><p>Claims: &#8220;Both APAP formulations were well tolerated.&#8221;</p></td><td align="left" colspan="1" rowspan="1">8 to 10&#160;h</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">57. 2000: Guide to pediatric medication and nutrition [<xref ref-type="bibr" rid="CR97">97</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;Usually well tolerated when used as directed,&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">58. 2001: Review describing treatment with paracetamol in infants [<xref ref-type="bibr" rid="CR98">98</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;generally considered a safe drug&#8221; without citation but warns of potential toxicity with glutathione depletion</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">59. 2001: Literature review describing perioperative use of high-dose of rectal paracetamol [<xref ref-type="bibr" rid="CR99">99</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;administration of high-dose rectal paracetamol in the perioperative period appears to be safe&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">60. 2001: Review describing paracetamol toxicity in children [<xref ref-type="bibr" rid="CR100">100</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: safety based on NAPQI production and glutathione levels without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">61. 2001: Review describing the neurobiology of pain [<xref ref-type="bibr" rid="CR101">101</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Makes no safety claim</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">62. 2001: Randomized, stratified, placebo-controlled, single-dose, double-blind, triple-dummy, single-center, parallel-group study with four treatments, one each of ibuprofen, ketoprofen, paracetamol, and placebo given for postoperative dental pain [<xref ref-type="bibr" rid="CR102">102</xref>]</td><td align="left" colspan="1" rowspan="1">NA: minimum age 16&#160;years, average age is 22.2&#160;years</td><td align="left" colspan="1" rowspan="1">NA: minimum age 16&#160;years, average age 22.2&#160;years</td><td align="left" colspan="1" rowspan="1">NA: minimum age 16&#160;years, average age 22.2&#160;years</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>63. 2001: Blinded study conducted to observe the analgesic efficacy of rectal and oral paracetamol in two separate groups in children after craniofacial surgery</p><p>[<xref ref-type="bibr" rid="CR103">103</xref>]</p></td><td align="left" colspan="1" rowspan="1">40 patients, average age is 10.3&#160;years</td><td align="left" colspan="1" rowspan="1">Paracetamol plasma concentrations and pain scores. Only side effect reported was vomiting. Makes no safety claims</td><td align="left" colspan="1" rowspan="1">24&#160;h</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">64. 2002: Review comparing the effects of paracetamol, NSAIDs, or their combination in postoperative pain management [<xref ref-type="bibr" rid="CR104">104</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;low incidence of adverse effects&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">65. 2002: Literature review describing paracetamol and ibuprofen use for fever treatment in children [<xref ref-type="bibr" rid="CR105">105</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;Both drugs appeared well tolerated and no evidence of difference in short-term adverse effects was observed&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">66. 2003: Editorial describing use of antipyretics [<xref ref-type="bibr" rid="CR106">106</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Editorial</td><td align="left" colspan="1" rowspan="1">Claims: paracetamol is &#8220;traditionally considered to be safe based on (a) large clinical experience over (a) long time&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Editorial</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">67. 2003: Erroneous or out of print citation*** [<xref ref-type="bibr" rid="CR107">107</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Erroneous or out of print citation</td><td align="left" colspan="1" rowspan="1">NA: erroneous or out of print citation</td><td align="left" colspan="1" rowspan="1">NA: Erroneous or out of print citation</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">68. 2003: Review describing anti-inflammatory agents and paracetamol in neonates [<xref ref-type="bibr" rid="CR108">108</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;paracetamol remains the drug of choice for antipyresis in neonates&#8221; and &#8220;the adverse effect of paracetamol is more favorable&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">69. 2003: Randomized, double-blind, placebo-controlled study with four treatments groups, ibuprofen, paracetamol, a combination of the two, and placebo. The purpose was to observe the analgesic efficacy of each treatment [<xref ref-type="bibr" rid="CR109">109</xref>]</td><td align="left" colspan="1" rowspan="1">80 children treated with paracetamol, age 1 to 6&#160;years; average age is 2.7&#160;years</td><td align="left" colspan="1" rowspan="1">Adverse events defined as retching, vomiting, abdominal pain, and dizziness</td><td align="left" colspan="1" rowspan="1">All children were kept in the PACU for 1.5&#160;h. The parents of the children were asked to record the well-being of their child until 24&#160;h after anesthesia</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">70. 2004: Pharmacokinetic study with a single intravenous dose of propacetamol [<xref ref-type="bibr" rid="CR110">110</xref>]</td><td align="left" colspan="1" rowspan="1">30 neonates, 24&#160;h after birth</td><td align="left" colspan="1" rowspan="1">Liver enzymes determined by blood samples</td><td align="left" colspan="1" rowspan="1">10&#160;h</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">71. 2004: Systematic review assessing the prevalence of aspirin-induced asthma in adults and children and other issues related to the syndrome [<xref ref-type="bibr" rid="CR111">111</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Makes no safety claim with respect to pediatric use</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">72. 2005: Review describing paracetamol&#8217;s tolerability profile [<xref ref-type="bibr" rid="CR112">112</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;Paracetamol is a very well tolerated drug at therapeutic doses&#8221; without citation, although this statement does not necessarily refer to pediatric use</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">73. 2005: Randomized, double-blind study with three treatments, one each of ibuprofen, paracetamol, and placebo given before surgery [<xref ref-type="bibr" rid="CR113">113</xref>]</td><td align="left" colspan="1" rowspan="1">25 children treated with paracetamol, age 3 to 12&#160;years</td><td align="left" colspan="1" rowspan="1">Agitation in recovery measured using Oucher&#8217;s scale</td><td align="left" colspan="1" rowspan="1">24&#160;h</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">74. 2005: Evaluation of pain management guidelines for tonsillectomy [<xref ref-type="bibr" rid="CR114">114</xref>]</td><td align="left" colspan="1" rowspan="1">37 children, age 5&#8211;11&#160;years</td><td align="left" colspan="1" rowspan="1">Evaluation of nausea and vomiting</td><td align="left" colspan="1" rowspan="1">16 to 20&#160;h</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">75. 2006: Practice guidelines [<xref ref-type="bibr" rid="CR115">115</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Practice guidelines</td><td align="left" colspan="1" rowspan="1">Makes no safety claim</td><td align="left" colspan="1" rowspan="1">NA: Practice guidelines</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">76. 2006: Practice guideline to assist poison center personnel with management of paracetamol poisoning [<xref ref-type="bibr" rid="CR116">116</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Guidelines</td><td align="left" colspan="1" rowspan="1">Makes no safety claim</td><td align="left" colspan="1" rowspan="1">NA: Guidelines</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">77&#8211;79. 2004&#8211;2010: Three textbooks [<xref ref-type="bibr" rid="CR117">117</xref>&#8211;<xref ref-type="bibr" rid="CR119">119</xref>] cited by Karbasi and colleagues [<xref ref-type="bibr" rid="CR120">120</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Textbooks</td><td align="left" colspan="1" rowspan="1">Not determined</td><td align="left" colspan="1" rowspan="1">NA: Textbooks</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">80. 2007: Review describing paracetamol safety and hepatotoxicity [<xref ref-type="bibr" rid="CR121">121</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;an excellent overall safety record&#8221; with infants and children without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">81. 2007. Open-label, single-sequence, multiple-dose study with intravenous paracetamol in adults [<xref ref-type="bibr" rid="CR122">122</xref>]</td><td align="left" colspan="1" rowspan="1">NA: study in adults</td><td align="left" colspan="1" rowspan="1">NA: study in adults</td><td align="left" colspan="1" rowspan="1">NA: study in adults</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">82. 2007: Randomized double-blind placebo-controlled study with paracetamol given for fever [<xref ref-type="bibr" rid="CR123">123</xref>]</td><td align="left" colspan="1" rowspan="1">103 children treated with paracetamol, age 6&#160;months to 6&#160;years; average age is 26.1&#160;months</td><td align="left" colspan="1" rowspan="1">Outcome measures included fever clearance time, rate of fall of temperature, percent reduction of temperature, proportion of afebrile children, symptomatic improvement, and clinical and biochemical adverse effects. Claims: &#8220;considered to be a safe drug at therapeutic levels.&#8221;</td><td align="left" colspan="1" rowspan="1">6&#160;h</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">83. 2007: Randomized, double-blind, placebo-controlled study with three treatments, one each of naproxen, paracetamol, and placebo before the induction of anethesia [<xref ref-type="bibr" rid="CR124">124</xref>]</td><td align="left" colspan="1" rowspan="1">30 children treated with paracetamol, age 1 to 6&#160;years, average age is 1.3&#160;years</td><td align="left" colspan="1" rowspan="1">Need for postoperative rescue fentanyl and the incidence of postoperative nausea and vomiting</td><td align="left" colspan="1" rowspan="1">Minimum of 2&#160;h</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">84. 2007: Study with zolmitriptan nasal spray, not paracetamol [<xref ref-type="bibr" rid="CR125">125</xref>]</td><td align="left" colspan="1" rowspan="1">NA: study not involving paracetamol</td><td align="left" colspan="1" rowspan="1">NA: study not involving paracetamol</td><td align="left" colspan="1" rowspan="1">NA: study not involving paracetamol</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">85. 2007: Guidelines for assessment and initial management of fever in children younger than 5&#160;years [<xref ref-type="bibr" rid="CR126">126</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Clinical guidelines</td><td align="left" colspan="1" rowspan="1">Makes no safety claim</td><td align="left" colspan="1" rowspan="1">NA: Clinical guidelines</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">86. 2007: Review describing systemic analgesics for children [<xref ref-type="bibr" rid="CR127">127</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;when the maximum daily dose of paracetamol is observed, it is well tolerated&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">87. 2009: Comparative study with three treatments: paracetamol, ketoprofen, and ibuprofen given for fever [<xref ref-type="bibr" rid="CR128">128</xref>]</td><td align="left" colspan="1" rowspan="1">112 children were treated with paracetamol, average age about 4&#160;years old</td><td align="left" colspan="1" rowspan="1">Children were monitored without observation of drug-related side effects. Makes no safety claim</td><td align="left" colspan="1" rowspan="1">Up to 48&#160;h</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">88. 2007: Randomized, controlled trial in which patients received either paracetamol or placebo for postoperative pain [<xref ref-type="bibr" rid="CR129">129</xref>]</td><td align="left" colspan="1" rowspan="1">29 infants were treated with paracetamol, age 0&#8211;2&#160;months</td><td align="left" colspan="1" rowspan="1">Did not report any adverse events. Measured the efficacy of paracetamol, not safety</td><td align="left" colspan="1" rowspan="1">48&#160;h</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">89. 2009: Review describing the Italian Pediatric Society guidelines on the management of fever in children [<xref ref-type="bibr" rid="CR130">130</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: paracetamol is &#8220;generally well tolerated&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">90. 2009: Review describing drugs of choice for sedation and analgesia in the NICU [<xref ref-type="bibr" rid="CR131">131</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Makes no safety claims</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">91. 2009: Review describing the perioperative use of paracetamol [<xref ref-type="bibr" rid="CR132">132</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: paracetamol is a &#8220;safe, well-tolerated drug with proven efficacy&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">92. 2009: Systematic review of the clinical safety and tolerability of ibuprofen compared with paracetamol in pediatric pain and fever [<xref ref-type="bibr" rid="CR133">133</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Makes no safety claims</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">93. 2009: Online survey of anesthetists and the current prescribing practice of i.v. paracetamol [<xref ref-type="bibr" rid="CR134">134</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Survey</td><td align="left" colspan="1" rowspan="1">Makes no safety claims</td><td align="left" colspan="1" rowspan="1">NA: Survey</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">94: 2010: Hemodynamic study with intravenous paracetamol in neonates [<xref ref-type="bibr" rid="CR135">135</xref>]</td><td align="left" colspan="1" rowspan="1">72 neonates, age 1 to 27&#160;days; average age is 3&#160;days</td><td align="left" colspan="1" rowspan="1">Assessment of hemodynamics. No safety claims made</td><td align="left" colspan="1" rowspan="1">6&#160;h</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">95: 2010: Review describing postoperative pain management [<xref ref-type="bibr" rid="CR136">136</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Makes no safety claim</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">96: 2010: Meta-analysis of efficacy and safety of ibuprofen and paracetamol in children and adults [<xref ref-type="bibr" rid="CR137">137</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims similar safety profiles between paracetamol and ibuprofen, but makes no absolute safety claim</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">97: 2011: Study of efficacy and safety in adults [<xref ref-type="bibr" rid="CR138">138</xref>]</td><td align="left" colspan="1" rowspan="1">NA: study in adults</td><td align="left" colspan="1" rowspan="1">NA: study in adults</td><td align="left" colspan="1" rowspan="1">NA: study in adults</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">98: 2011: Literature review of clinical trials of intravenous paracetamol for postoperative pain [<xref ref-type="bibr" rid="CR139">139</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: it &#8220;has been well known as a safe and effective&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">99: 2012: Review of efficacy and pharmacokinetics of paracetamol in pediatric patients [<xref ref-type="bibr" rid="CR140">140</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Makes no safety claims</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">100: 2012: Retrospective study using data collected on pediatric surgery patients to identify the status and risk factors of major infections [<xref ref-type="bibr" rid="CR28">28</xref>]</td><td align="left" colspan="1" rowspan="1">230 patients, age 0 to 15&#160;years, average age is 4.28&#160;years</td><td align="left" colspan="1" rowspan="1">Postoperative fever and its etiologies, mortality discharge, and rates of re-open sternotomy reintubation</td><td align="left" colspan="1" rowspan="1">1&#160;year</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">101. 2013: Case series evaluating the efficacy of intravenous paracetamol in preterm infants with hemodynamically significant patent ductus arteriosus (hsPDA) [<xref ref-type="bibr" rid="CR141">141</xref>]</td><td align="left" colspan="1" rowspan="1">10 preterm infants, age 2 to 15&#160;days</td><td align="left" colspan="1" rowspan="1">Pre- and posttreatment levels of liver enzymes</td><td align="left" colspan="1" rowspan="1">3&#160;days</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">102. 2013: Mechanistic study in laboratory animals [<xref ref-type="bibr" rid="CR142">142</xref>]</td><td align="left" colspan="1" rowspan="1">NA: study in laboratory animals</td><td align="left" colspan="1" rowspan="1">Makes no safety claim</td><td align="left" colspan="1" rowspan="1">NA: study in laboratory animals</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">103. 2014: Literature review assessing liver toxicity due to paracetamol in children [<xref ref-type="bibr" rid="CR143">143</xref>]</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;doses of less than 75&#160;mg/kg/day of paracetamol are safe for children younger than 6&#160;years of age&#8221; without citation</td><td align="left" colspan="1" rowspan="1">NA: Review</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">104. 1984: Prospective study evaluating paracetamol overdose and its treatment in young children [<xref ref-type="bibr" rid="CR144">144</xref>]</td><td align="left" colspan="1" rowspan="1">417 children, age 14&#160;days to 5&#160;years</td><td align="left" colspan="1" rowspan="1"><p>Outcome measures were post-overdose blood work, including markers for liver and kidney functions</p><p>Claims: it &#8220;seems to have a wide margin of safety&#8221; and is &#8220;likely the safest antipyretic for the young child.&#8221;</p></td><td align="left" colspan="1" rowspan="1">72&#160;h (duration of treatment with antidote (NAC))</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">105. 1996: Pharmacokinetic study of one single oral dose of paracetamol in children with chronic liver disease [<xref ref-type="bibr" rid="CR145">145</xref>]</td><td align="left" colspan="1" rowspan="1">13 children, age 7&#160;months to 12&#160;years</td><td align="left" colspan="1" rowspan="1">Claims: in children with chronic liver disease, &#8220;at least for single doses, there is no cause for concern in the use of paracetamol.&#8221;</td><td align="left" colspan="1" rowspan="1">Up to 36&#160;h</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">106. 1997: Randomized, prospective, double-blind study with two treatments, one each of paracetamol and paracetamol plus codeine, and promethazine for premedication and analgesia for myringotomy [<xref ref-type="bibr" rid="CR146">146</xref>]</td><td align="left" colspan="1" rowspan="1">95 children, age 1 to 12&#160;years</td><td align="left" colspan="1" rowspan="1"><p>Side effects considered included vomiting, pruritus, respiratory depression, and agitation</p><p>Claims: paracetamol is an effective and safe premedication for minor middle ear surgery</p></td><td align="left" colspan="1" rowspan="1">2&#160;h</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">107. 2001: Pharmacokinetic study of paracetamol given to children for tonsillectomy pain [<xref ref-type="bibr" rid="CR147">147</xref>]</td><td align="left" colspan="1" rowspan="1">182 children, age 6 to 12&#160;years</td><td align="left" colspan="1" rowspan="1"><p>Liver enzymes were measured 2 to 3&#160;days after surgery</p><p>Claims: a dose of &#8220;40&#160;mg/kg by mouth preoperatively is a safe and effective treatment for postoperative pain relief for children weighing 20&#8211;50&#160;kg.&#8221;</p></td><td align="left" colspan="1" rowspan="1">2 to 3&#160;days</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">108. 2001: Study evaluating occult acetaminophen hepatotoxicity in hospitalized children receiving acetaminophen [<xref ref-type="bibr" rid="CR148">148</xref>]</td><td align="left" colspan="1" rowspan="1">100 children, average age 9.3&#8201;&#177;&#8201;5.9&#160;years</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;routine use of acetaminophen at therapeutic doses in ill, hospitalized children and adolescents appears safe&#8221;</td><td align="left" colspan="1" rowspan="1">Up to 72&#160;h</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">109. 2001: Randomized, double-blind multinational trial evaluating the antipyretic effects of dipyrone, ibuprofen, and paracetamol [<xref ref-type="bibr" rid="CR149">149</xref>]</td><td align="left" colspan="1" rowspan="1">628 children, age 6&#160;months to 6&#160;years</td><td align="left" colspan="1" rowspan="1"><p>Most adverse events were of gastrointestinal nature, such as vomiting and diarrhea</p><p>Claims: all three drugs, including paracetamol, appeared &#8220;safe and effective in reducing temperature.&#8221;</p></td><td align="left" colspan="1" rowspan="1">14&#160;days</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">110. 2003: Randomized, single-blind, parallel, multicenter trial with three treatments given for surgery, one of paracetamol and two of ketoprofen lysine, which were given on a body weight basis [<xref ref-type="bibr" rid="CR150">150</xref>]</td><td align="left" colspan="1" rowspan="1">85 children, age 6 to 14&#160;years</td><td align="left" colspan="1" rowspan="1"><p>Outcome measures included non-specified adverse events, physical findings, and vital signs</p><p>Claims: &#8220;perioperative rectal paracetamol doses of 15&#8211;20&#160;mg/kg were effective and safe.&#8221;</p></td><td align="left" colspan="1" rowspan="1">8&#160;h</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">111. 2004: Randomized, double-blind study in which patients either received paracetamol or ibuprofen to treat uncomplicated typhoid fever [<xref ref-type="bibr" rid="CR29">29</xref>]</td><td align="left" colspan="1" rowspan="1">80 children, age 2 to 14&#160;years</td><td align="left" colspan="1" rowspan="1"><p>Outcome measures based on resolution of clinical symptoms and signs, time to discharge from hospital, fever defervescence, and area under temperature&#8211;time curve measured with respect to a baseline of 37 <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$^\circ$$\end{document}</tex-math><mml:math id="M2"><mml:msup><mml:mrow/><mml:mo>&#8728;</mml:mo></mml:msup></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="431_2022_4407_Article_IEq1.gif"/></alternatives></inline-formula> C</p><p>Claims: &#8220;Both antipyretics appeared to be safe.&#8221;</p></td><td align="left" colspan="1" rowspan="1">4 to 6&#160;weeks (recurrence of typhoid fever only)</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">112. 2008: Prospective, randomized, double-blind, placebo-controlled study comparing the antipyretic efficacy of paracetamol and paracetamol alternated with ibuprofen [<xref ref-type="bibr" rid="CR151">151</xref>]</td><td align="left" colspan="1" rowspan="1">38 children, 6&#160;months to 6&#160;years</td><td align="left" colspan="1" rowspan="1"><p>Adverse events included diarrhea, flatulence, emesis, decreased appetite, epigastric pain, nausea, headache, and insomnia</p><p>Claims: &#8220;Both regiments were well tolerated.&#8221;</p></td><td align="left" colspan="1" rowspan="1">6&#160;h</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">113. 2011: Randomized, double-blind, placebo-controlled study with three treatments, one each of paracetamol, ketoprofen lysine salt, and placebo given for pain control in children with pharyngotonsillitis [<xref ref-type="bibr" rid="CR152">152</xref>]</td><td align="left" colspan="1" rowspan="1">97 children, 6 to 12&#160;years</td><td align="left" colspan="1" rowspan="1"><p>Four adverse events were observed. These included bronchitis and rash in the ketoprofen lysine salt group, and diarrhea and cough in the placebo group</p><p>Claims: &#8220;a single oral dose of paracetamol or ketoprofen lysine salt are safe.&#8221;</p></td><td align="left" colspan="1" rowspan="1">4&#160;days</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">114. 2013: Randomized, non-blinded, parallel-controlled trial studying the efficacy and safety profiles of oral paracetamol and ibuprofen with patent ductus arteriosus [<xref ref-type="bibr" rid="CR153">153</xref>]</td><td align="left" colspan="1" rowspan="1">160 infants, gestational age up to 34&#160;weeks and postnatal age up to 14&#160;weeks</td><td align="left" colspan="1" rowspan="1"><p>Outcome measures were the rates of ductal closure of the two drugs and other adverse events such as hemorrhage, kidney failure, and gastrointestinal problems</p><p>Claims: &#8220;this study clearly showed that a two-course regimen of paracetamol for premature infants is safe and feasible&#8221;</p></td><td align="left" colspan="1" rowspan="1">Up to 72&#160;h</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">115. 2014: Case series evaluating paracetamol effectiveness, safety, and blood level monitoring during patent ductus arteriosus closure [<xref ref-type="bibr" rid="CR154">154</xref>]</td><td align="left" colspan="1" rowspan="1">7 infants, gestational age 26 to 30&#160;weeks</td><td align="left" colspan="1" rowspan="1">Claims: &#8220;paracetamol is an effective and safe therapeutic option for PDA closure.&#8221;</td><td align="left" colspan="1" rowspan="1">24&#160;h</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">116. 2014: Case series evaluating the efficacy of IV paracetamol for the treatment of patent ductus arteriosus [<xref ref-type="bibr" rid="CR155">155</xref>]</td><td align="left" colspan="1" rowspan="1">8 preterm neonates, gestational age 24 to 28&#160;weeks</td><td align="left" colspan="1" rowspan="1"><p>Safety measures included serum concentration of liver enzymes, total and direct bilirubin, creatinine, and urea nitrogen</p><p>Claims: paracetamol can be considered a &#8220;safe therapy for the treatment of patent arteriosus in neonates.&#8221;</p></td><td align="left" colspan="1" rowspan="1">Time not specified: monitored during therapy only, no follow-up</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">117. 2015: Randomized controlled trial comparing enteral paracetamol and intravenous indomethacin for closure of patent ductus arteriosus [<xref ref-type="bibr" rid="CR156">156</xref>]</td><td align="left" colspan="1" rowspan="1">77 preterm neonates, average gestational age in the paracetamol group is 28.5&#160;weeks and 28.9&#160;weeks in the indomethacin group</td><td align="left" colspan="1" rowspan="1"><p>Primary outcome measure was PDA closure. Secondary outcomes included renal impairment, GI bleed, NEC, sepsis, pulmonary hemorrhage, ROP, IVH and PVL, and O2 requirement</p><p>Claims: &#8220;enteral paracetamol is safe but not superior to intravenous indomethacin.&#8221;</p></td><td align="left" colspan="1" rowspan="1">7&#160;days</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">118. 2016: Randomized study comparing oral acetaminophen and ibuprofen in premature infants with patent ductus arteriosus [<xref ref-type="bibr" rid="CR157">157</xref>]</td><td align="left" colspan="1" rowspan="1">120 infants, average age in the paracetamol group is 2.85&#160;days and 3.42&#160;days in the ibuprofen group</td><td align="left" colspan="1" rowspan="1"><p>Primary outcome measure was PDA closure on echocardiography. Secondary outcomes included the safety of both drugs and adverse events, such as oliguria, IVH, tendency to bleeding, NEC, and death</p><p>Claims: &#8220;the results clearly show that both drugs are well-tolerated and safe.&#8221;</p></td><td align="left" colspan="1" rowspan="1">Monitored during 3&#160;days of therapy only, no follow-up</td><td align="left" colspan="1" rowspan="1">0</td></tr><tr><td align="left" colspan="1" rowspan="1">119. 2016: Case series evaluating IV paracetamol as a treatment for patent ductus arteriosus [<xref ref-type="bibr" rid="CR158">158</xref>]</td><td align="left" colspan="1" rowspan="1">11 neonates, gestational age 23 to 30.3&#160;weeks</td><td align="left" colspan="1" rowspan="1"><p>No adverse or side effects observed</p><p>Safety was monitored by collecting data regarding serum concentration of liver enzymes, total and direct bilirubin, creatinine, and urea nitrogen</p><p>Claims: paracetamol can be considered a &#8220;safe therapy for the treatment of PDA in preterm infants.&#8221;</p></td><td align="left" colspan="1" rowspan="1">Monitored during 3&#160;days of therapy only, no follow-up</td><td align="left" colspan="1" rowspan="1">0</td></tr></tbody></table><table-wrap-foot><p>*This article is cited as &#8220;Renn E. The antipyretic use of paracetamol versus ibuprofen in a pediatric care setting. Physical Therapy. 2000; 25:395&#8211;397.&#8221; This reference does not apparently exist. The volume number corresponding to the year 2000 for the journal Physical Therapy is 80, not 25. We were unable to determine what actual article it may have originally referred to. **The Canadian Pediatric Society paper from 1998 was mis-cited as being from 2000 in one instance. ***This article, cited as Kehlet and Werner (2003) from the journal Drugs, Volume 63, pp 15&#8211;22 (Spec no 2), does not exist on the journal&#8217;s website for unknown reasons</p></table-wrap-foot></table-wrap></p><p id="Par32">Several studies emerged as popular citations for the claim that paracetamol use in infants or children is safe when used as directed. Only 19 articles were cited more than twice, and the most popular article [<xref ref-type="bibr" rid="CR26">26</xref>] was cited a total of 13 times (Table <xref rid="Tab2" ref-type="table">2</xref>) by the 218 articles we identified. However, in some cases, well cited articles did not make original claims of safety, and are therefore not included in Table <xref rid="Tab2" ref-type="table">2</xref>. For example, an article by Perrott and colleagues in 2004 [<xref ref-type="bibr" rid="CR27">27</xref>] was cited a total of 7 total times by the 218 articles we identified. However, Perrott&#8217;s article, being a review, does not make original claims of safety, but rather cites additional articles as the authority for assurance of safety (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). Thus, Perrott&#8217;s article is not included in Table <xref rid="Tab2" ref-type="table">2</xref> as an original source for the claim that use of paracetamol is safe for infants and children when used as directed.</p><p id="Par33">Of the 103 articles cited as authority for the safety of paracetamol use in infants or children, 27 did not make claims of safety and did not address safety experimentally (Table <xref rid="Tab2" ref-type="table">2</xref>). Thus, 76 of the 103 articles did address safety, and 48 of these 76 articles (63%) had already been identified in the original 218 articles gleaned from the Medline search. Of the 103 articles, 36 articles described experimental studies which involved paracetamol use in infants or children. As described above, from the original 218 articles making claims of safety, 16 uncited articles described experimental studies that were used to support claims of safety. Thus, 52 studies in total (36 cited plus 16 uncited) provided experimental evidence supporting claims of safety. Although several of those 52 studies provided measures of liver function (Table <xref rid="Tab2" ref-type="table">2</xref>), none of the studies provided any assessment of neuropsychiatric function. Furthermore, the median follow-up time of all 52 studies was 48&#160;h (Fig.&#160;<xref rid="Fig2" ref-type="fig">2</xref>), far too short to identify any long-term effects of drug exposure on neuropsychiatric function. Six studies had follow-up times of longer than 10&#160;days, although only one study [<xref ref-type="bibr" rid="CR28">28</xref>] evaluated patients beyond 6&#160;weeks. However, all experimental studies were blind to any potential effects of drug exposure on long-term neuropsychiatric function. For example, although patients were followed for a full year in one study [<xref ref-type="bibr" rid="CR28">28</xref>], the only endpoint measured was re-admission for surgery. As another example, a study following patients for up to 6&#160;weeks measured only recurrence of typhoid fever beyond the initial treatment period of the study [<xref ref-type="bibr" rid="CR29">29</xref>].<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Maximum follow-up times for 49 of the 52 studies describing experiments designed to test the safety of paracetamol in infants or children. One study [<xref ref-type="bibr" rid="CR28">28</xref>] monitoring readmission for surgery for 1&#160;year is omitted from the graph. Two other studies [<xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR155">155</xref>] observing patients during their inpatient visit or treatment period did not specify duration of monitoring, and therefore could not be included in the graph. The five studies monitoring outcomes for 4&#160;weeks or longer did not monitor neuropsychiatric function</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="431_2022_4407_Fig2_HTML.jpg"/></fig></p><p id="Par34">The path from more recent papers to the original research addressing the safety of paracetamol in infants and children was sometimes convoluted. In one notable case, a popular citation did not did appear in&#160;the literature (Table <xref rid="Tab2" ref-type="table">2</xref>). Not only did the volume and journal number not match, but the title could not be found elsewhere. As another example, the citations reporting safety of paracetamol use in children reported by Temple and colleagues in 2017 [<xref ref-type="bibr" rid="CR30">30</xref>] are illustrated in Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>. This article provides a detailed description of three prior reports to the European Medicines Agency (reports 24,570, 24,571, and 47,402) which, together, according to the authors, &#8220;confirm that the recommended standard paracetamol dose of 10 to 15&#160;mg/kg is a safe and effective dose for use in pediatric patients when administered as a single dose or as multiple doses for up to 72&#160;h.&#8221; However, the only safety measure used in the three studies was ALT levels as a marker for liver function, assessed for a maximum of 72&#160;h. In addition to the three reports described in their publication, Temple and colleagues cite 10 additional articles as sources for safety, including the claim that paracetamol has a &#8220;well-established efficacy and favorable safety profile&#8221; (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). Among these 10 papers is a clinical trial [<xref ref-type="bibr" rid="CR31">31</xref>] that addresses efficacy but not safety, and refers to two other papers that address safety, one by Lesko [<xref ref-type="bibr" rid="CR26">26</xref>]. The paper by Lesko contradicts the view that paracetamol is safe, finding that paracetamol is significantly worse than ibuprofen in terms of risk for outpatient visits following treatment of children with asthma. Another of the articles cited by Temple in 2017, a review written by Temple more than 30&#160;years before [<xref ref-type="bibr" rid="CR32">32</xref>], cites a paper in the Federal Register [<xref ref-type="bibr" rid="CR33">33</xref>] as the source for the statement that &#8220;Paracetamol is relatively free of side effects and has a wide margin of safety between therapeutic doses and toxic doses.&#8221; The document in the Federal Register [<xref ref-type="bibr" rid="CR33">33</xref>], a lengthy treatise primarily focused on determination of the appropriate dose for adults of salicylates in general and aspirin in particular, in turn cites two papers involving safety studies of paracetamol in the human pediatric population. One of those studies [<xref ref-type="bibr" rid="CR34">34</xref>] evaluated 98 children using a blinded approach comparing aspirin and paracetamol, and monitored the children for only 6&#160;h. The other study [<xref ref-type="bibr" rid="CR35">35</xref>] monitored 20 children following administration of both aspirin and paracetamol. In that study, monitoring occurred for 6&#160;h or less, and no information was provided regarding particular side effects that were being assessed. Importantly, the Federal Register [<xref ref-type="bibr" rid="CR33">33</xref>] attributed their view that paracetamol has &#8220;a wide range of safety&#8221; to laboratory animal studies showing that the lethal dose of paracetamol is significantly greater than the dose administered to humans. Unfortunately, studies had not been conducted at that time showing that paracetamol induces permanent neurodevelopmental injury in laboratory animals at far lower doses than the lethal dose [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>], similar to doses administered to infants and children.</p></sec><sec id="Sec4"><title>Discussion</title><p id="Par35">Our initial search of the PubMed<sup>&#174;</sup> Database and review of more than 3000 titles and abstracts yielded 218 papers making claims that paracetamol is safe for infants and children when used as directed. Claims of safety in those 218 papers were traced back to 103 articles shown in Table <xref rid="Tab2" ref-type="table">2</xref>, but less than 20 of those were cited more than twice, indicating that a limited number of studies are considered key or cornerstone to the view that paracetamol is safe for use in infants or children.</p><p id="Par36">Finding more than 200 articles making claims that paracetamol is safe and/or well tolerated for infants and children when used as directed, this study confirms the view that the drug is widely thought to be safe, despite the absence of any study demonstrating that it is safe for neurodevelopment. The fact that 27 out of 103 articles citated as authority for the safety of the drug did not, in fact, demonstrate safety or make safety claims might suggest that the safety of paracetamol is taken for granted, and is not carefully considered. This view is supported by the observation that one popular citation for safety does not exist in the literature.</p><p id="Par37">This study does not in any way suggest that the effects of early life exposure to paracetamol on neurodevelopment have never been examined. Indeed, the first study to address the issue was published in 2008 by several now-prominent scientists, then at the University of California San Diego and at San Diego State University [<xref ref-type="bibr" rid="CR22">22</xref>]. This case-controlled, survey-based study raised substantial concerns, as mentioned in the Introduction. Further, studies in animal models evaluating the issue have been conducted [<xref ref-type="bibr" rid="CR19">19</xref>&#8211;<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR36">36</xref>], all indicating that the drug is not safe for neurodevelopment despite a wide range of study designs. In addition, as described in the Introduction, at least 14 cohort analyses [<xref ref-type="bibr" rid="CR5">5</xref>&#8211;<xref ref-type="bibr" rid="CR18">18</xref>] have indicated that exposure to paracetamol during pregnancy is not safe for neurodevelopment of the fetus. Thus, the present study does not demonstrate that the safety of paracetamol for neurodevelopment has never been examined, but rather demonstrates that assertions that paracetamol is safe during early development when used as recommended are based on a lack of knowledge regarding the effects of paracetamol on neurodevelopment.</p><p id="Par38">The difficulty in moving forward into the clinical arena based on current scientific knowledge is perhaps reflected in the debate surrounding a recent consensus statement supported by almost 100 clinicians and scientists [<xref ref-type="bibr" rid="CR37">37</xref>] urging caution with the use of paracetamol during pregnancy. This consensus statement of 2021 was met with some skepticism, including an announcement by the American College of Obstetricians and Gynecologists (ACOG) asserting that &#8220;Most importantly, patients should not be frightened away from the many benefits of acetaminophen (paracetamol)&#8221; [<xref ref-type="bibr" rid="CR38">38</xref>]. Furthermore, the ACOG asserts that &#8220;This consensus statement, and studies that have been conducted in the past, show no clear evidence that proves a direct relationship between the prudent use of acetaminophen (paracetamol) during any trimester and fetal developmental issues&#8221; [<xref ref-type="bibr" rid="CR38">38</xref>]. This latter assertion by the ACOG could technically be considered correct if studies in animal models are ignored, but it demands a level of proof that is not met by the over one dozen studies of cohort data with a wide range of controls for confounding factors via multivariate analysis.</p><p id="Par39">In their response to the 2021 consensus statement, the ACOG clarified their demands for proof, stating that &#8220;ACOG&#8217;s clinical guidance remains the same and physicians should not change clinical practice until definitive prospective research is done&#8221; [<xref ref-type="bibr" rid="CR38">38</xref>]. However, it is difficult to rationalize the need for such a high level of certainty regarding a drug never demonstrated to be safe or life-saving, where judgment should presumably err on the side of caution and avoidance of harm. Indeed, the drug would not meet current safety standards during preclinical testing due to adverse, long-term neurological effects in laboratory animals, and thus would never reach phase I testing under the current regulatory system. Furthermore, the potential difficulty in obtaining the prospective, controlled study demanded by the ACOG is of concern. Although a study during pregnancy might be envisioned, exposures after birth are likely also important (see Introduction), and therefore must be taken into account in any long-term study. The magnitude and difficulty of a sufficiently powered study, starting from conception and extending into early childhood, is considerable. For example, a group at the University of Oulu conducted a 5-year prospective, placebo-controlled study on 49 children following exposure to paracetamol (<italic toggle="yes">n</italic>&#8201;=&#8201;19) or to saline control (<italic toggle="yes">n</italic>&#8201;=&#8201;20) [<xref ref-type="bibr" rid="CR39">39</xref>]. However, as the authors point out, their study is underpowered to test the impact of paracetamol on neurodevelopment. In addition, the authors did not control for exposure during all 5&#160;years of the study, but rather only for exposure during a single, 4-day period. Furthermore, it is difficult to imagine a placebo control for treating fevers in babies and children, since withholding paracetamol may need to be accompanied by non-medicinal methods of treating some fevers [<xref ref-type="bibr" rid="CR40">40</xref>]. Even more importantly, the University of Oulu study used the intravenous formulation of paracetamol rather than the much more commonly used oral formulation. The intravenous formula contains an antidote for paracetamol toxicity (cysteine, a glutathione precursor), which should, hypothetically, block much of the adverse effects of paracetamol. Since this antidote is not present in the commonly used oral formulation, the University of Oulu study, even if it had been much larger and controlled for drug exposure over a period of years, would still not apply to most cases of paracetamol use. It should be noted that, in laboratory animals, exposure during the postpartum period to currently accepted levels of the intravenous formulation of paracetamol with the antidote present causes dramatic increases in asocial behavior later in life [<xref ref-type="bibr" rid="CR36">36</xref>]. Thus, the argument is not that use of paracetamol with the antidote is safe, but rather that, hypothetically, some of the more serious adverse effects might be prevented by inclusion of the antidote with the drug.</p><p id="Par40">The difficulty in obtaining prospective, controlled studies evaluating the safety of paracetamol in humans is, as outlined above, a complex problem involving large numbers of patients and years of study time, difficulty in establishing controls, and the variable presence of an antidote for paracetamol toxicity in paracetamol formulations. These issues point toward the importance of careful examination of presently available evidence or, as the case may be, the lack of evidence regarding the safety of paracetamol for neurodevelopment.</p></sec><sec id="Sec5"><title>Conclusions</title><p id="Par41">Although not the intended purpose of this systematic review with citation tracking, it demonstrated that paracetamol has been proven safe for liver function in infants and in small children, even at doses higher than those currently recommended. During the course of this review with citation tracking, an assumption was repeatedly encountered: because the target of paracetamol toxicity in adults is the liver, demonstration of safety in infants and children need only be tested in the liver. This assumption was/is held despite the fact that the target tissue for drug function is in the central nervous system, not the liver. A similar assumption has proven tragically fatal in the past, when it was assumed that metabolism of the antibiotic chloramphenicol was the same in infants as in adults. In that case, administration of the drug in infants led to a number of deaths [<xref ref-type="bibr" rid="CR41">41</xref>&#8211;<xref ref-type="bibr" rid="CR43">43</xref>] before the problem was identified.</p><p id="Par42">Despite apparently being taken for granted, this study demonstrates that paracetamol was never shown to be safe for neurodevelopment. This conclusion is consistent with emerging studies showing a connection between paracetamol use during development and long-term neuropsychiatric disfunction as described in the Introduction. This conclusion is also consistent with emerging studies in animal models showing exquisite sensitivity of long-term behavior to early life exposure to paracetamol at near-therapeutic doses.</p></sec><sec sec-type="supplementary-material"><title>Supplementary information</title><sec id="Sec6"><p>Below is the link to the electronic supplementary material.<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="431_2022_4407_MOESM1_ESM.docx" position="float" orientation="portrait"><caption><p>Supplementary file1 (DOCX 510 KB)</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="MOESM2" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="431_2022_4407_MOESM2_ESM.pdf" position="float" orientation="portrait"><caption><p>Supplementary file2 (PDF 152 KB)</p></caption></media></supplementary-material></p></sec></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>ALT</term><def><p id="Par5">Alanine aminotransferase</p></def></def-item><def-item><term>APAP</term><def><p id="Par6">N-acetyl-para-aminophenol (acetaminophen or paracetamol)</p></def></def-item><def-item><term>AST</term><def><p id="Par7">Aspartate aminotransferase</p></def></def-item><def-item><term>BMI</term><def><p id="Par8">Body mass index</p></def></def-item><def-item><term>BUN</term><def><p id="Par9">Blood urea nitrogen</p></def></def-item><def-item><term>GGT</term><def><p id="Par10">Gamma glutamyltransferase</p></def></def-item><def-item><term>IVH</term><def><p id="Par11">Intraventricular hemorrhage</p></def></def-item><def-item><term>NEC</term><def><p id="Par12">Necrotizing enterocolitis</p></def></def-item><def-item><term>PDA</term><def><p id="Par13">Ductus arteriosus</p></def></def-item><def-item><term>PVL</term><def><p id="Par14">Periventricular leukomalacia</p></def></def-item><def-item><term>ROP</term><def><p id="Par15">Retinopathy of prematurity</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>The authors wish to thank John and Susan Poulton for their encouragement and support of this work.</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>JCH, JTS, VGL, AP, and WP reviewed and analyzed the thousands of published papers identified in this study. LGA, VL, and WP designed the study and drafted the manuscript. All authors contributed to editing the manuscript. In addition, VL performed the literature search.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The dataset analyzed (PubMed<sup>&#174;</sup>) is in the public domain.</p></notes><notes notes-type="data-availability"><title>Code availability</title><p>Not applicable.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethical approval and consent to participate</title><p id="Par43">Not applicable.</p></notes><notes id="FPar2"><title>Consent to participate</title><p id="Par44">Not applicable.</p></notes><notes id="FPar3"><title>Consent for publication</title><p id="Par45">Not applicable.</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interests</title><p id="Par46">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Alemany</surname><given-names>S</given-names></name><etal/></person-group><article-title>Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: meta-analysis in six European population-based cohorts</article-title><source>Eur J Epidemiol</source><year>2021</year><volume>36</volume><issue>10</issue><fpage>993</fpage><lpage>1004</lpage><pub-id pub-id-type="pmid">34046850</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10654-021-00754-4</pub-id><pub-id pub-id-type="pmcid">PMC8542535</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Doed&#233;e</surname><given-names>AMCM</given-names></name><etal/></person-group><article-title>Effects of prophylactic and therapeutic paracetamol treatment during vaccination on hepatitis B antibody levels in adults: two open-label, randomized controlled trials</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><issue>6</issue><fpage>e98175</fpage><lpage>e98175</lpage><pub-id pub-id-type="pmid">24897504</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0098175</pub-id><pub-id pub-id-type="pmcid">PMC4045752</pub-id></element-citation></ref><ref id="CR3"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Betz</surname><given-names>MG</given-names></name><name name-style="western"><surname>Grunfeld</surname><given-names>AF</given-names></name></person-group><article-title>&#8216;<italic toggle="yes">Fever phobia</italic>&#8217; <italic toggle="yes">in the emergency department: a survey of children</italic>&#8217;<italic toggle="yes">s caregivers</italic></article-title><source>Eur J Emerg Med</source><year>2006</year><volume>13</volume><issue>3</issue><fpage>129</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">16679875</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.mej.0000194401.15335.c7</pub-id></element-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parker</surname><given-names>W</given-names></name><etal/></person-group><article-title>The role of oxidative stress, inflammation and acetaminophen exposure from birth to early childhood in the induction of autism</article-title><source>J Int Med Res</source><year>2017</year><volume>45</volume><issue>2</issue><fpage>407</fpage><lpage>438</lpage><pub-id pub-id-type="pmid">28415925</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0300060517693423</pub-id><pub-id pub-id-type="pmcid">PMC5536672</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="other">Stergiakouli E, Thapar A, Smith GD (2016) Association of acetaminophen use during pregnancy with behavioral problems in childhood: evidence against confounding.&#160;JAMA pediatrics&#160;170(10):964-970<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamapediatrics.2016.1775</pub-id><pub-id pub-id-type="pmcid">PMC5300094</pub-id><pub-id pub-id-type="pmid">27533796</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brandlistuen</surname><given-names>RE</given-names></name><etal/></person-group><article-title>Prenatal paracetamol exposure and child neurodevelopment: a sibling-controlled cohort study</article-title><source>Int J Epidemiol</source><year>2013</year><volume>42</volume><issue>6</issue><fpage>1702</fpage><lpage>1713</lpage><pub-id pub-id-type="pmid">24163279</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ije/dyt183</pub-id><pub-id pub-id-type="pmcid">PMC3887567</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liew</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders</article-title><source>JAMA Pediatr</source><year>2014</year><volume>168</volume><issue>4</issue><fpage>313</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">24566677</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamapediatrics.2013.4914</pub-id></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liew</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Paracetamol use during pregnancy and attention and executive function in offspring at age 5 years</article-title><source>Int J Epidemiol</source><year>2016</year><volume>45</volume><issue>6</issue><fpage>2009</fpage><lpage>2017</lpage><pub-id pub-id-type="pmid">28031314</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ije/dyw296</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="other">Thompson JM et al (2014)&#160;Associations between acetaminophen use during pregnancy and ADHD symptoms measured at ages 7 and 11 years. PLoS One&#160;9(9): p. e108210<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0108210</pub-id><pub-id pub-id-type="pmcid">PMC4177119</pub-id><pub-id pub-id-type="pmid">25251831</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liew</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Prenatal use of acetaminophen and child IQ: a Danish cohort study</article-title><source>Epidemiology</source><year>2016</year><volume>27</volume><issue>6</issue><fpage>912</fpage><lpage>918</lpage><pub-id pub-id-type="pmid">27479646</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/EDE.0000000000000540</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liew</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Maternal use of acetaminophen during pregnancy and risk of autism spectrum disorders in childhood: a Danish national birth cohort study</article-title><source>Autism Res</source><year>2016</year><volume>9</volume><issue>9</issue><fpage>951</fpage><lpage>958</lpage><pub-id pub-id-type="pmid">26688372</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/aur.1591</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Avella-Garcia</surname><given-names>CB</given-names></name><etal/></person-group><article-title>Acetaminophen use in pregnancy and neurodevelopment: attention function and autism spectrum symptoms</article-title><source>Int J Epidemiol</source><year>2016</year><volume>45</volume><issue>6</issue><fpage>1987</fpage><lpage>1996</lpage><pub-id pub-id-type="pmid">27353198</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ije/dyw115</pub-id></element-citation></ref><ref id="CR13"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skovlund</surname><given-names>E</given-names></name><etal/></person-group><article-title>Language competence and communication skills in 3-year-old children after prenatal exposure to analgesic opioids</article-title><source>Pharmacoepidemiol Drug Saf</source><year>2017</year><volume>26</volume><issue>6</issue><fpage>625</fpage><lpage>634</lpage><pub-id pub-id-type="pmid">28168770</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/pds.4170</pub-id></element-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vlenterie</surname><given-names>R</given-names></name><etal/></person-group><article-title>Neurodevelopmental problems at 18 months among children exposed to paracetamol in utero: a propensity score matched cohort study</article-title><source>Int J Epidemiol</source><year>2016</year><volume>45</volume><issue>6</issue><fpage>1998</fpage><lpage>2008</lpage><pub-id pub-id-type="pmid">27585674</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ije/dyw192</pub-id><pub-id pub-id-type="pmcid">PMC5841617</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="other">Ystrom E et al (2017)&#160;Prenatal exposure to acetaminophen and risk of ADHD<italic toggle="yes">.</italic> Pediatrics&#160;140(5)<pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.2016-3840</pub-id><pub-id pub-id-type="pmcid">PMC5654387</pub-id><pub-id pub-id-type="pmid">29084830</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="other">Ji Y et al (2019)&#160;Association of cord plasma biomarkers of in utero acetaminophen exposure with risk of attention-deficit/hyperactivity disorder and autism spectrum disorder in childhood. JAMA Psychiatry 1&#8211;11<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamapsychiatry.2019.3259</pub-id><pub-id pub-id-type="pmcid">PMC6822099</pub-id><pub-id pub-id-type="pmid">31664451</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bittker</surname><given-names>SS</given-names></name><name name-style="western"><surname>Bell</surname><given-names>KR</given-names></name></person-group><article-title>Acetaminophen, antibiotics, ear infection, breastfeeding, vitamin D drops, and autism: an epidemiological study</article-title><source>Neuropsychiatr Dis Treat</source><year>2018</year><volume>14</volume><fpage>1399</fpage><lpage>1414</lpage><pub-id pub-id-type="pmid">29910617</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/NDT.S158811</pub-id><pub-id pub-id-type="pmcid">PMC5987866</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tovo-Rodrigues</surname><given-names>L</given-names></name><etal/></person-group><article-title>Is intrauterine exposure to acetaminophen associated with emotional and hyperactivity problems during childhood? Findings from the 2004 Pelotas birth cohort</article-title><source>BMC Psychiatry</source><year>2018</year><volume>18</volume><issue>1</issue><fpage>368</fpage><pub-id pub-id-type="pmid">30458756</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12888-018-1942-1</pub-id><pub-id pub-id-type="pmcid">PMC6245767</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Philippot</surname><given-names>G</given-names></name><etal/></person-group><article-title>Adult neurobehavioral alterations in male and female mice following developmental exposure to paracetamol (acetaminophen): characterization of a critical period</article-title><source>J Appl Toxicol</source><year>2017</year><volume>37</volume><issue>10</issue><fpage>1174</fpage><lpage>1181</lpage><pub-id pub-id-type="pmid">28448685</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jat.3473</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Viberg</surname><given-names>H</given-names></name><etal/></person-group><article-title>Paracetamol (Acetaminophen) administration during neonatal brain development affects cognitive function and alters its analgesic and anxiolytic response in adult male mice</article-title><source>Toxicol Sci</source><year>2013</year><volume>138</volume><issue>1</issue><fpage>139</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">24361869</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/toxsci/kft329</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hay-Schmidt</surname><given-names>A</given-names></name><etal/></person-group><article-title>Prenatal exposure to paracetamol/acetaminophen and precursor aniline impairs masculinisation of male brain and behaviour</article-title><source>Reproduction</source><year>2017</year><volume>154</volume><issue>2</issue><fpage>145</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">28559473</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1530/REP-17-0165</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="other">Schultz ST et al (2008) Acetaminophen (paracetamol) use, measles-mumps-rubella vaccination, and autistic disorder. The results of a parent survey. Autism&#160;12(3):293&#8211;307.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1362361307089518</pub-id><pub-id pub-id-type="pmid">18445737</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Frisch</surname><given-names>M</given-names></name><name name-style="western"><surname>Simonsen</surname><given-names>J</given-names></name></person-group><article-title>Ritual circumcision and risk of autism spectrum disorder in 0- to 9-year-old boys: national cohort study in Denmark</article-title><source>J R Soc Med</source><year>2015</year><volume>108</volume><issue>7</issue><fpage>266</fpage><lpage>279</lpage><pub-id pub-id-type="pmid">25573114</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0141076814565942</pub-id><pub-id pub-id-type="pmcid">PMC4530408</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goin-Kochel</surname><given-names>RP</given-names></name><name name-style="western"><surname>Mire</surname><given-names>SS</given-names></name><name name-style="western"><surname>Dempsey</surname><given-names>AG</given-names></name></person-group><article-title>Emergence of autism spectrum disorder in children from simplex families: relations to parental perceptions of etiology</article-title><source>J Autism Dev Disord</source><year>2015</year><volume>45</volume><issue>5</issue><fpage>1451</fpage><lpage>1463</lpage><pub-id pub-id-type="pmid">25398603</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10803-014-2310-8</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mercer</surname><given-names>L</given-names></name><etal/></person-group><article-title>Parental perspectives on the causes of an autism spectrum disorder in their children</article-title><source>J Genet Couns</source><year>2006</year><volume>15</volume><issue>1</issue><fpage>41</fpage><lpage>50</lpage><pub-id pub-id-type="pmid">16547798</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10897-005-9002-7</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Lesko SM, Mitchell AA (1999) The safety of acetaminophen and ibuprofen among children younger than two years old. Pediatrics&#160;104(4):e39<pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.104.4.e39</pub-id><pub-id pub-id-type="pmid">10506264</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Perrott</surname><given-names>DA</given-names></name><etal/></person-group><article-title>Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever: a meta-analysis</article-title><source>Arch Pediatr Adolesc Med</source><year>2004</year><volume>158</volume><issue>6</issue><fpage>521</fpage><lpage>526</lpage><pub-id pub-id-type="pmid">15184213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archpedi.158.6.521</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vijarnsorn</surname><given-names>C</given-names></name><etal/></person-group><article-title>Postoperative fever and major infections after pediatric cardiac surgery</article-title><source>J Med Assoc Thai</source><year>2012</year><volume>95</volume><issue>6</issue><fpage>761</fpage><lpage>770</lpage><pub-id pub-id-type="pmid">22774619</pub-id></element-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vinh</surname><given-names>H</given-names></name><etal/></person-group><article-title>Double blind comparison of ibuprofen and paracetamol for adjunctive treatment of uncomplicated typhoid fever</article-title><source>Pediatr Infect Dis J</source><year>2004</year><volume>23</volume><issue>3</issue><fpage>226</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">15014297</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.inf.0000114905.87426.c2</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Temple</surname><given-names>AR</given-names></name><etal/></person-group><article-title>Comparison of the efficacy and safety of 2 acetaminophen dosing regimens in febrile infants and children: a report on 3 legacy studies</article-title><source>The journal of pediatric pharmacology and therapeutics: JPPT: the official journal of PPAG</source><year>2017</year><volume>22</volume><issue>1</issue><fpage>22</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">28337078</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5863/1551-6776-22.1.22</pub-id><pub-id pub-id-type="pmcid">PMC5341528</pub-id></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shepherd</surname><given-names>M</given-names></name><name name-style="western"><surname>Aickin</surname><given-names>R</given-names></name></person-group><article-title>Paracetamol versus ibuprofen: a randomized controlled trial of outpatient analgesia efficacy for paediatric acute limb fractures</article-title><source>Emerg Med Australas</source><year>2009</year><volume>21</volume><issue>6</issue><fpage>484</fpage><lpage>490</lpage><pub-id pub-id-type="pmid">20002719</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1742-6723.2009.01232.x</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Temple</surname><given-names>AR</given-names></name></person-group><article-title>Review of comparative antipyretic activity in children</article-title><source>Am J Med</source><year>1983</year><volume>75</volume><issue>5a</issue><fpage>38</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">6359865</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0002-9343(83)90231-0</pub-id></element-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="other">Federal Register&#160;(1977)&#160;42(131):35366&#8211;35413</mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="other">Tarlin L et al (1972)&#160;&#160;A comparison of the antipyretic effect of acetaminophen and aspirin. Another approach to poison prevention. Am J Dis Child&#160;124(6):880&#8211;2<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archpedi.1972.02110180082011</pub-id><pub-id pub-id-type="pmid">4565223</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Steele</surname><given-names>RW</given-names></name><etal/></person-group><article-title>Oral antipyretic therapy: evaluation of aspirin-acetaminophen combination</article-title><source>Am J Dis Child</source><year>1972</year><volume>123</volume><issue>3</issue><fpage>204</fpage><lpage>206</lpage><pub-id pub-id-type="pmid">5026198</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archpedi.1972.02110090074006</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="other">Suda N et al (2022) Therapeutic doses of paracetamol with co-administration of cysteine and mannitol during early development result in long term behavioral changes in laboratory rats. PLoS One 16(6):e0253543<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0253543</pub-id><pub-id pub-id-type="pmcid">PMC8232535</pub-id><pub-id pub-id-type="pmid">34170958</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bauer</surname><given-names>AZ</given-names></name><etal/></person-group><article-title>Paracetamol use during pregnancy &#8212; a call for precautionary action</article-title><source>Nat Rev Endocrinol</source><year>2021</year><volume>17</volume><issue>12</issue><fpage>757</fpage><lpage>766</lpage><pub-id pub-id-type="pmid">34556849</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41574-021-00553-7</pub-id><pub-id pub-id-type="pmcid">PMC8580820</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="other">ACOG (2021)&#160;ACOG Response to consensus statement on paracetamol use during pregnancy. ACOG News</mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="other">Juuj&#228;rvi S et al (2021) Trial of paracetamol for premature newborns: five-year follow-up. J Matern Fetal Neonatal Med 1&#8211;3<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/14767058.2021.1875444</pub-id><pub-id pub-id-type="pmid">33478294</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="other">AAP (2015)&#160;Treating a fever without medicine. Caring for your baby and young child: birth to age 5.&#160;Available from: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.healthychildren.org/English/health-issues/conditions/fever/Pages/Treating-a-Fever-Without-Medicine.aspx">https://www.healthychildren.org/English/health-issues/conditions/fever/Pages/Treating-a-Fever-Without-Medicine.aspx</ext-link></mixed-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lischner</surname><given-names>H</given-names></name><etal/></person-group><article-title>An outbreak of neonatal deaths among term infants associated with administration of chloramphenicol</article-title><source>J Pediatr</source><year>1961</year><volume>59</volume><issue>1</issue><fpage>21</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">13762638</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0022-3476(61)80205-9</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sutherland</surname><given-names>JM</given-names></name></person-group><article-title>Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol</article-title><source>AMA J Dis Child</source><year>1959</year><volume>97</volume><issue>6</issue><fpage>761</fpage><lpage>767</lpage><pub-id pub-id-type="pmid">13649107</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archpedi.1959.02070010763001</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Burns</surname><given-names>LE</given-names></name><name name-style="western"><surname>Hodgman</surname><given-names>JE</given-names></name><name name-style="western"><surname>Cass</surname><given-names>AB</given-names></name></person-group><article-title>Fatal circulatory collapse in premature infants receiving chloramphenicol</article-title><source>N Engl J Med</source><year>1959</year><volume>261</volume><fpage>1318</fpage><lpage>1321</lpage><pub-id pub-id-type="pmid">13806261</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJM195912242612604</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>H&#228;m&#228;l&#228;inen</surname><given-names>ML</given-names></name><etal/></person-group><article-title>Ibuprofen or acetaminophen for the acute treatment of migraine in children: a double-blind, randomized, placebo-controlled, crossover study</article-title><source>Neurology</source><year>1997</year><volume>48</volume><issue>1</issue><fpage>103</fpage><lpage>107</lpage><pub-id pub-id-type="pmid">9008503</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/wnl.48.1.103</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="other">Rumack BH (1978)&#160;Aspirin versus acetaminophen: a comparative view. Pediatrics&#160;62(5 Pt 2 Suppl):943&#8211;6<pub-id pub-id-type="pmid">569271</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Litalien</surname><given-names>C</given-names></name><name name-style="western"><surname>Jacqz-Aigrain</surname><given-names>E</given-names></name></person-group><article-title>Risks and benefits of nonsteroidal anti-inflammatory drugs in children: a comparison with paracetamol</article-title><source>Paediatr Drugs</source><year>2001</year><volume>3</volume><issue>11</issue><fpage>817</fpage><lpage>858</lpage><pub-id pub-id-type="pmid">11735667</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00128072-200103110-00004</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Drwal-Klein</surname><given-names>LA</given-names></name><name name-style="western"><surname>Phelps</surname><given-names>SJ</given-names></name></person-group><article-title>Antipyretic therapy in the febrile child</article-title><source>Clin Pharm</source><year>1992</year><volume>11</volume><issue>12</issue><fpage>1005</fpage><lpage>1021</lpage><pub-id pub-id-type="pmid">1286550</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sullivan</surname><given-names>JE</given-names></name><name name-style="western"><surname>Farrar</surname><given-names>HC</given-names></name></person-group><article-title>Fever and antipyretic use in children</article-title><source>Pediatrics</source><year>2011</year><volume>127</volume><issue>3</issue><fpage>580</fpage><lpage>587</lpage><pub-id pub-id-type="pmid">21357332</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.2010-3852</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Temple</surname><given-names>AR</given-names></name></person-group><article-title>Pediatric dosing of acetaminophen</article-title><source>Pediatr Pharmacol (New York)</source><year>1983</year><volume>3</volume><issue>3&#8211;4</issue><fpage>321</fpage><lpage>327</lpage><pub-id pub-id-type="pmid">6677877</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lesko</surname><given-names>SM</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>AA</given-names></name></person-group><article-title>An assessment of the safety of pediatric ibuprofen</article-title><source>A practitioner-based randomized clinical trial Jama</source><year>1995</year><volume>273</volume><issue>12</issue><fpage>929</fpage><lpage>933</lpage><pub-id pub-id-type="pmid">7884951</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Society</collab><name name-style="western"><surname>C.P.</surname></name></person-group><article-title>Acetaminophen and ibuprofen in the management of fever and mild to moderate pain in children</article-title><source>Pediatr Child Health</source><year>1998</year><volume>3</volume><issue>4</issue><fpage>273</fpage><lpage>274</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/pch/3.4.273</pub-id><pub-id pub-id-type="pmcid">PMC2851353</pub-id><pub-id pub-id-type="pmid">20401262</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>American Academy of Pediatrics Committee on Drugs</collab></person-group><article-title>commentary on acetaminophen</article-title><source>Pediatrics</source><year>1978</year><volume>61</volume><issue>1</issue><fpage>108</fpage><lpage>112</lpage><pub-id pub-id-type="pmid">263837</pub-id></element-citation></ref><ref id="CR53"><label>53.</label><mixed-citation publication-type="other">Lovejoy FH JR (1978) Aspirin and acetaminophen: a comparative view of their antipyretic and analgesic activity. Pediatrics 62(5 Pt 2 Suppl):904&#8211;9<pub-id pub-id-type="pmid">364400</pub-id></mixed-citation></ref><ref id="CR54"><label>54.</label><mixed-citation publication-type="other">Prescott LF (1996)&#160;Paracetamol overdose, in Paracetamol (acetaminophen): a critical bibliographic review.&#160;Taylor &amp; Francis Ltd. 451</mixed-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lesko</surname><given-names>SM</given-names></name><name name-style="western"><surname>Mitchell</surname><given-names>AA</given-names></name></person-group><article-title>Renal function after short-term ibuprofen use in infants and children</article-title><source>Pediatrics</source><year>1997</year><volume>100</volume><issue>6</issue><fpage>954</fpage><lpage>957</lpage><pub-id pub-id-type="pmid">9374563</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.100.6.954</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>BJ</given-names></name><etal/></person-group><article-title>Pediatric intravenous paracetamol (propacetamol) pharmacokinetics: a population analysis</article-title><source>Paediatr Anaesth</source><year>2005</year><volume>15</volume><issue>4</issue><fpage>282</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">15787918</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1460-9592.2005.01455.x</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zuppa</surname><given-names>AF</given-names></name><etal/></person-group><article-title>Safety and population pharmacokinetic analysis of intravenous acetaminophen in neonates, infants, children, and adolescents with pain or fever</article-title><source>J Pediatr Pharmacol Ther</source><year>2011</year><volume>16</volume><issue>4</issue><fpage>246</fpage><lpage>261</lpage><pub-id pub-id-type="pmid">22768009</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5863/1551-6776-16.4.246</pub-id><pub-id pub-id-type="pmcid">PMC3385039</pub-id></element-citation></ref><ref id="CR58"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sutton</surname><given-names>E</given-names></name><name name-style="western"><surname>Soyka</surname><given-names>LF</given-names></name></person-group><article-title>How safe is acetaminophen? Some practical cautions with this widely used agent</article-title><source>Clin Pediatr (Phila)</source><year>1973</year><volume>12</volume><issue>12</issue><fpage>692</fpage><lpage>696</lpage><pub-id pub-id-type="pmid">4586647</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/000992287301201210</pub-id></element-citation></ref><ref id="CR59"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yaffe</surname><given-names>SJ</given-names></name></person-group><article-title>Comparative efficacy of aspirin and acetaminophen in the reduction of fever in children</article-title><source>Arch Intern Med</source><year>1981</year><volume>141</volume><issue>3</issue><fpage>286</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">7008732</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archinte.141.3.286</pub-id></element-citation></ref><ref id="CR60"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Depr&#233;</surname><given-names>M</given-names></name><etal/></person-group><article-title>Tolerance and pharmacokinetics of propacetamol, a paracetamol formulation for intravenous use</article-title><source>Fundam Clin Pharmacol</source><year>1992</year><volume>6</volume><issue>6</issue><fpage>259</fpage><lpage>262</lpage><pub-id pub-id-type="pmid">1487229</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1472-8206.1992.tb00119.x</pub-id></element-citation></ref><ref id="CR61"><label>61.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Anand</surname><given-names>KJS</given-names></name><name name-style="western"><surname>Shapiro</surname><given-names>BS</given-names></name><name name-style="western"><surname>Berde</surname><given-names>CB</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Anand</surname><given-names>KJS</given-names></name><name name-style="western"><surname>McGrath</surname><given-names>PJ</given-names></name></person-group><article-title>Pharmacotherapy with systemic analgesics</article-title><source>Pain research and clinical management</source><year>1993</year><publisher-loc>New York</publisher-loc><publisher-name>Elsevier</publisher-name><fpage>155</fpage><lpage>198</lpage></element-citation></ref><ref id="CR62"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McIntyre</surname><given-names>J</given-names></name><name name-style="western"><surname>Hull</surname><given-names>D</given-names></name></person-group><article-title>Comparing efficacy and tolerability of ibuprofen and paracetamol in fever</article-title><source>Arch Dis Child</source><year>1996</year><volume>74</volume><issue>2</issue><fpage>164</fpage><lpage>167</lpage><pub-id pub-id-type="pmid">8660083</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/adc.74.2.164</pub-id><pub-id pub-id-type="pmcid">PMC1511501</pub-id></element-citation></ref><ref id="CR63"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Holford</surname><given-names>NHG</given-names></name></person-group><article-title>Rectal paracetamol dosing regimens: determination by computer simulation</article-title><source>Pediatr Anesth</source><year>1997</year><volume>7</volume><issue>6</issue><fpage>451</fpage><lpage>455</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1460-9592.1997.d01-125.x</pub-id><pub-id pub-id-type="pmid">9365970</pub-id></element-citation></ref><ref id="CR64"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Birmingham</surname><given-names>PK</given-names></name><etal/></person-group><article-title>Twenty-four-hour pharmacokinetics of rectal acetaminophen in children: an old drug with new recommendations</article-title><source>Anesthesiology</source><year>1997</year><volume>87</volume><issue>2</issue><fpage>244</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">9286887</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00000542-199708000-00010</pub-id></element-citation></ref><ref id="CR65"><label>65.</label><mixed-citation publication-type="other">van Lingen, RA et al (1999)&#160;Pharmacokinetics and metabolism of rectally administered paracetamol in preterm neonates.&#160;Arch Dis Child: Fetal Neonatal Ed 80(1):F59&#8211;F63<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/fn.80.1.f59</pub-id><pub-id pub-id-type="pmcid">PMC1720876</pub-id><pub-id pub-id-type="pmid">10325815</pub-id></mixed-citation></ref><ref id="CR66"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Autret-Leca</surname><given-names>E</given-names></name><name name-style="western"><surname>Gibb</surname><given-names>IA</given-names></name><name name-style="western"><surname>Goulder</surname><given-names>MA</given-names></name></person-group><article-title>Ibuprofen versus paracetamol in pediatric fever: objective and subjective findings from a randomized, blinded study</article-title><source>Curr Med Res Opin</source><year>2007</year><volume>23</volume><issue>9</issue><fpage>2205</fpage><lpage>2211</lpage><pub-id pub-id-type="pmid">17686209</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1185/030079907X223323</pub-id></element-citation></ref><ref id="CR67"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allegaert</surname><given-names>K</given-names></name><etal/></person-group><article-title>Hepatic tolerance of repeated intravenous paracetamol administration in neonates</article-title><source>Paediatr Anaesth</source><year>2008</year><volume>18</volume><issue>5</issue><fpage>388</fpage><lpage>392</lpage><pub-id pub-id-type="pmid">18384338</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1460-9592.2008.02535.x</pub-id></element-citation></ref><ref id="CR68"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maund</surname><given-names>E</given-names></name><etal/></person-group><article-title>Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs for the reduction in morphine-related side-effects after major surgery: a systematic review</article-title><source>Br J Anaesth</source><year>2011</year><volume>106</volume><issue>3</issue><fpage>292</fpage><lpage>297</lpage><pub-id pub-id-type="pmid">21285082</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bja/aeq406</pub-id></element-citation></ref><ref id="CR69"><label>69.</label><mixed-citation publication-type="other">Temple AR, Temple BR, Kuffner EK (2013)&#160;Dosing and antipyretic efficacy of oral acetaminophen in children. Clin Ther&#160;35(9):1361&#8211;75.e1&#8211;45<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clinthera.2013.06.022</pub-id><pub-id pub-id-type="pmid">23972576</pub-id></mixed-citation></ref><ref id="CR70"><label>70.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Woodbury</surname><given-names>D</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Goodman</surname><given-names>L</given-names></name><name name-style="western"><surname>Gilman</surname><given-names>A</given-names></name></person-group><article-title>Analgesics and antipyretics</article-title><source>The pharmacological basis of therapeutics</source><year>1965</year><publisher-loc>Ney York, NY</publisher-loc><publisher-name>The Macmillan Company</publisher-name><fpage>330</fpage><lpage>335</lpage></element-citation></ref><ref id="CR71"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Eden</surname><given-names>AN</given-names></name><name name-style="western"><surname>Kaufman</surname><given-names>A</given-names></name></person-group><article-title>Clinical comparison of three antipyretic agents</article-title><source>Am J Dis Child</source><year>1967</year><volume>114</volume><issue>3</issue><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">6038265</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archpedi.1967.02090240098007</pub-id></element-citation></ref><ref id="CR72"><label>72.</label><mixed-citation publication-type="other">Temple AR (1978)&#160;Pathophysiology of aspirin overdosage toxicity, with implications for management. Pediatrics 62(5 Pt 2 Suppl):873&#8211;6<pub-id pub-id-type="pmid">364398</pub-id></mixed-citation></ref><ref id="CR73"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mitchell</surname><given-names>AA</given-names></name><etal/></person-group><article-title>Acetaminophen and aspirin: prescription, use, and accidental ingestion among children</article-title><source>Am J Dis Child</source><year>1982</year><volume>136</volume><issue>11</issue><fpage>976</fpage><lpage>979</lpage><pub-id pub-id-type="pmid">7124704</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archpedi.1982.03970470020005</pub-id></element-citation></ref><ref id="CR74"><label>74.</label><mixed-citation publication-type="other">Nahata M, Powell D (1982)&#160;Kinetics of acetaminophen (Ac) following single strength (SS-Ac) vs double strength (DS-Ac) administration to febrile children. Clin Res 30(2)</mixed-citation></ref><ref id="CR75"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ragg</surname><given-names>P</given-names></name><name name-style="western"><surname>Davidson</surname><given-names>A</given-names></name></person-group><article-title>Comparison of the efficacy of paracetamol versus paracetamol, codeine and promethazine (Painstop&#174;) for premedication and analgesia for myringotomy in children</article-title><source>Anaesth Intensive Care</source><year>1997</year><volume>25</volume><issue>1</issue><fpage>29</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">9075510</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0310057X9702500105</pub-id></element-citation></ref><ref id="CR76"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Choonara</surname><given-names>IA</given-names></name><name name-style="western"><surname>Harris</surname><given-names>F</given-names></name></person-group><article-title>Adverse drug reactions in medical inpatients</article-title><source>Arch Dis Child</source><year>1984</year><volume>59</volume><issue>6</issue><fpage>578</fpage><lpage>580</lpage><pub-id pub-id-type="pmid">6742882</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/adc.59.6.578</pub-id><pub-id pub-id-type="pmcid">PMC1628777</pub-id></element-citation></ref><ref id="CR77"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Ibuprofen vs acetaminophen in children</collab></person-group><source>Med Lett Drugs Ther</source><year>1989</year><volume>31</volume><issue>807</issue><fpage>109</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">2593974</pub-id></element-citation></ref><ref id="CR78"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Truog</surname><given-names>R</given-names></name><name name-style="western"><surname>Anand</surname><given-names>KJ</given-names></name></person-group><article-title>Management of pain in the postoperative neonate</article-title><source>Clin Perinatol</source><year>1989</year><volume>16</volume><issue>1</issue><fpage>61</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">2656066</pub-id></element-citation></ref><ref id="CR79"><label>79.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Insel</surname><given-names>P</given-names></name><etal/></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Gilman</surname><given-names>A</given-names></name><etal/></person-group><article-title>Analgesic-antipyretics and anti-inflammatory agents; drugs employed in the treatment of rheumatoid arthritis and gout</article-title><source>The pharmacological basis of therapeutics</source><year>1990</year><publisher-loc>Elmsford, NY</publisher-loc><publisher-name>Pergamon Press</publisher-name><fpage>656</fpage><lpage>659</lpage></element-citation></ref><ref id="CR80"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Penna</surname><given-names>A</given-names></name><name name-style="western"><surname>Buchanan</surname><given-names>N</given-names></name></person-group><article-title>Paracetamol poisoning in children and hepatotoxicity</article-title><source>Br J Clin Pharmacol</source><year>1991</year><volume>32</volume><issue>2</issue><fpage>143</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">1931463</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2125.1991.tb03873.x</pub-id><pub-id pub-id-type="pmcid">PMC1368435</pub-id></element-citation></ref><ref id="CR81"><label>81.</label><mixed-citation publication-type="other">Prescott LF (1992) The hepatotoxicity of non-steroidal anti-inflammatory drugs, in Side-effects of anti-inflammatory drugs 3, K.D. Rainsford and G.P. Velo, Eds&#160;Springer Dordrecht Netherlands 176&#8211;187</mixed-citation></ref><ref id="CR82"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Walson</surname><given-names>PD</given-names></name><etal/></person-group><article-title>Comparison of multidose ibuprofen and acetaminophen therapy in febrile children</article-title><source>Am J Dis Child</source><year>1992</year><volume>146</volume><issue>5</issue><fpage>626</fpage><lpage>632</lpage><pub-id pub-id-type="pmid">1621669</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archpedi.1992.02160170106025</pub-id></element-citation></ref><ref id="CR83"><label>83.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Lorin</surname><given-names>MI</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Oski</surname><given-names>FA</given-names></name><name name-style="western"><surname>Deangelis</surname><given-names>CD</given-names></name></person-group><article-title>Pathogenesis of fever and its treatment</article-title><source>Principles and practice of pediatrics</source><year>1994</year><publisher-loc>Philadelphia</publisher-loc><publisher-name>J.B. Lippincott</publisher-name><fpage>1111</fpage><lpage>1113</lpage></element-citation></ref><ref id="CR84"><label>84.</label><mixed-citation publication-type="other">Wilson D (1995)&#160;Assessing and managing the febrile child. Nurse Pract&#160;20(11 Pt 1):59&#8211;60, 68&#8211;74<pub-id pub-id-type="pmid">8587746</pub-id></mixed-citation></ref><ref id="CR85"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>B</given-names></name><name name-style="western"><surname>Kanagasundarum</surname><given-names>S</given-names></name><name name-style="western"><surname>Woollard</surname><given-names>G</given-names></name></person-group><article-title>Analgesic efficacy of paracetamol in children using tonsillectomy as a pain model</article-title><source>Anaesth Intensive Care</source><year>1996</year><volume>24</volume><issue>6</issue><fpage>669</fpage><lpage>673</lpage><pub-id pub-id-type="pmid">8971314</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0310057X9602400606</pub-id></element-citation></ref><ref id="CR86"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Romej</surname><given-names>M</given-names></name><etal/></person-group><article-title>Effect of preemptive acetaminophen on postoperative pain scores and oral fluid intake in pediatric tonsillectomy patients</article-title><source>Aana j</source><year>1996</year><volume>64</volume><issue>6</issue><fpage>535</fpage><lpage>540</lpage><pub-id pub-id-type="pmid">9204788</pub-id></element-citation></ref><ref id="CR87"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Vauzelle-Kervro&#235;dan</surname><given-names>F</given-names></name><etal/></person-group><article-title>Equivalent antipyretic activity of ibuprofen and paracetamol in febrile children</article-title><source>J Pediatr</source><year>1997</year><volume>131</volume><issue>5</issue><fpage>683</fpage><lpage>687</lpage><pub-id pub-id-type="pmid">9403646</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0022-3476(97)70093-3</pub-id></element-citation></ref><ref id="CR88"><label>88.</label><mixed-citation publication-type="other">Korpela RMD, Korvenoja PMD, Olli AMDP (1999) Meretoja, Morphine-sparing effect of acetaminophen in pediatric day-case surgery Anesthesiology. J Am Soc Anesthesiol 91(2):442&#8211;447<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00000542-199908000-00019</pub-id><pub-id pub-id-type="pmid">10443608</pub-id></mixed-citation></ref><ref id="CR89"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Lingen</surname><given-names>RA</given-names></name><etal/></person-group><article-title>Multiple-dose pharmacokinetics of rectally administered acetaminophen in term infants</article-title><source>Clin Pharmacol Ther</source><year>1999</year><volume>66</volume><issue>5</issue><fpage>509</fpage><lpage>515</lpage><pub-id pub-id-type="pmid">10579478</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0009-9236(99)70014-7</pub-id></element-citation></ref><ref id="CR90"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dahl</surname><given-names>V</given-names></name><name name-style="western"><surname>Raeder</surname><given-names>JC</given-names></name></person-group><article-title>Non-opioid postoperative analgesia</article-title><source>Acta Anaesthesiol Scand</source><year>2000</year><volume>44</volume><issue>10</issue><fpage>1191</fpage><lpage>1203</lpage><pub-id pub-id-type="pmid">11065198</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1034/j.1399-6576.2000.441003.x</pub-id></element-citation></ref><ref id="CR91"><label>91.</label><mixed-citation publication-type="other">Hahn TW et al (2000) Pharmacokinetics of rectal paracetamol after repeated dosing in children. BJA: British Journal of Anaesthesia&#160;85(4):512&#8211;519<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bja/85.4.512</pub-id><pub-id pub-id-type="pmid">11064607</pub-id></mixed-citation></ref><ref id="CR92"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mohler</surname><given-names>CR</given-names></name><etal/></person-group><article-title>Prospective evaluation of mild to moderate pediatric acetaminophen exposures</article-title><source>Ann Emerg Med</source><year>2000</year><volume>35</volume><issue>3</issue><fpage>239</fpage><lpage>244</lpage><pub-id pub-id-type="pmid">10692190</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0196-0644(00)70074-6</pub-id></element-citation></ref><ref id="CR93"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Prescott</surname><given-names>LF</given-names></name></person-group><article-title>Paracetamol: past, present, and future</article-title><source>Am J Ther</source><year>2000</year><volume>7</volume><issue>2</issue><fpage>143</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">11319582</pub-id></element-citation></ref><ref id="CR94"><label>94.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>R&#248;msing</surname><given-names>J</given-names></name><etal/></person-group><article-title>Diclofenac or acetaminophen for analgesia in paediatric tonsillectomy outpatients</article-title><source>Acta Anaesthesiol Scand</source><year>2000</year><volume>44</volume><issue>3</issue><fpage>291</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">10714842</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1034/j.1399-6576.2000.440312.x</pub-id></element-citation></ref><ref id="CR95"><label>95.</label><element-citation publication-type="book"><person-group person-group-type="author"><collab>World Health</collab><name name-style="western"><surname>O. </surname></name></person-group><source>Handbook : IMCI integrated management of childhood illness</source><year>2000</year><publisher-loc>Geneva</publisher-loc><publisher-name>World Health Organization</publisher-name></element-citation></ref><ref id="CR96"><label>96.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>JT</given-names></name><etal/></person-group><article-title>Acetaminophen controlled-release sprinkles versus acetaminophen immediate-release elixir in febrile children</article-title><source>J Clin Pharmacol</source><year>2000</year><volume>40</volume><issue>4</issue><fpage>360</fpage><lpage>369</lpage><pub-id pub-id-type="pmid">10761163</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/00912700022009062</pub-id></element-citation></ref><ref id="CR97"><label>97.</label><mixed-citation publication-type="other">Zenk KJ, Sills J, Koeppel R (2000) Neonatal medications &amp; nutrition: a comprehensive guide. 2nd ed., C. Rait, Editor. NICU INK Book Publishers: Santa Rosa, CA 1&#8211;7</mixed-citation></ref><ref id="CR98"><label>98.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Arana</surname><given-names>A</given-names></name><name name-style="western"><surname>Morton</surname><given-names>NS</given-names></name><name name-style="western"><surname>Hansen</surname><given-names>TG</given-names></name></person-group><article-title>Treatment with paracetamol in infants</article-title><source>Acta Anaesthesiol Scand</source><year>2001</year><volume>45</volume><issue>1</issue><fpage>20</fpage><lpage>29</lpage><pub-id pub-id-type="pmid">11152028</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1034/j.1399-6576.2001.450104.x</pub-id></element-citation></ref><ref id="CR99"><label>99.</label><mixed-citation publication-type="other">Buck ML (2001) Perioperative use of high-dose rectal acetaminophen. Pediatric Pharmacotherapy&#160;7(9)</mixed-citation></ref><ref id="CR100"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Acetaminophen toxicity in children</collab></person-group><source>Pediatrics</source><year>2001</year><volume>108</volume><issue>4</issue><fpage>1020</fpage><pub-id pub-id-type="pmid">11581462</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.108.4.1020</pub-id></element-citation></ref><ref id="CR101"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fitzgerald</surname><given-names>M</given-names></name><name name-style="western"><surname>Beggs</surname><given-names>S</given-names></name></person-group><article-title>The neurobiology of pain: developmental aspects</article-title><source>Neuroscientist</source><year>2001</year><volume>7</volume><issue>3</issue><fpage>246</fpage><lpage>257</lpage><pub-id pub-id-type="pmid">11499403</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/107385840100700309</pub-id></element-citation></ref><ref id="CR102"><label>102.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Olson</surname><given-names>NZ</given-names></name><etal/></person-group><article-title>Onset of analgesia for liquigel ibuprofen 400 mg, acetaminophen 1000 mg, ketoprofen 25 mg, and placebo in the treatment of postoperative dental pain</article-title><source>J Clin Pharmacol</source><year>2001</year><volume>41</volume><issue>11</issue><fpage>1238</fpage><lpage>1247</lpage><pub-id pub-id-type="pmid">11697757</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/00912700122012797</pub-id></element-citation></ref><ref id="CR103"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van der Marel</surname><given-names>CD</given-names></name><etal/></person-group><article-title>Analgesic efficacy of rectal versus oral acetaminophen in children after major craniofacial surgery</article-title><source>Clin Pharmacol Ther</source><year>2001</year><volume>70</volume><issue>1</issue><fpage>82</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">11452248</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1067/mcp.2001.116794</pub-id></element-citation></ref><ref id="CR104"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hyllested</surname><given-names>M</given-names></name><etal/></person-group><article-title>Comparative effect of paracetamol, NSAIDs or their combination in postoperative pain management: a qualitative review</article-title><source>Br J Anaesth</source><year>2002</year><volume>88</volume><issue>2</issue><fpage>199</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">11878654</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bja/88.2.199</pub-id></element-citation></ref><ref id="CR105"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Purssell</surname><given-names>E</given-names></name></person-group><article-title>Treating fever in children: paracetamol or ibuprofen?</article-title><source>Br J Community Nurs</source><year>2002</year><volume>7</volume><issue>6</issue><fpage>316</fpage><lpage>320</lpage><pub-id pub-id-type="pmid">12066066</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.12968/bjcn.2002.7.6.10477</pub-id></element-citation></ref><ref id="CR106"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amdekar</surname><given-names>YK</given-names></name></person-group><article-title>Rational use of antipyretics</article-title><source>Indian Pediatr</source><year>2003</year><volume>40</volume><issue>6</issue><fpage>541</fpage><lpage>544</lpage><pub-id pub-id-type="pmid">12824663</pub-id></element-citation></ref><ref id="CR107"><label>107.</label><mixed-citation publication-type="other">Kehlet H, Werner MU (2003)&#160;[Role of paracetamol in the acute pain management]. Drugs&#160;63 Spec No 2: p. 15&#8211;22<pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003495-200363992-00004</pub-id><pub-id pub-id-type="pmid">14758787</pub-id></mixed-citation></ref><ref id="CR108"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Morris</surname><given-names>JL</given-names></name><name name-style="western"><surname>Rosen</surname><given-names>DA</given-names></name><name name-style="western"><surname>Rosen</surname><given-names>KR</given-names></name></person-group><article-title>Nonsteroidal anti-inflammatory agents in neonates</article-title><source>Pediatr Drugs</source><year>2003</year><volume>5</volume><issue>6</issue><fpage>385</fpage><lpage>405</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00128072-200305060-00004</pub-id><pub-id pub-id-type="pmid">12765488</pub-id></element-citation></ref><ref id="CR109"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Viitanen</surname><given-names>H</given-names></name><etal/></person-group><article-title>Analgesic efficacy of rectal acetaminophen and ibuprofen alone or in combination for paediatric day-case adenoidectomy</article-title><source>Br J Anaesth</source><year>2003</year><volume>91</volume><issue>3</issue><fpage>363</fpage><lpage>367</lpage><pub-id pub-id-type="pmid">12925475</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bja/aeg196</pub-id></element-citation></ref><ref id="CR110"><label>110.</label><mixed-citation publication-type="other">Allegaert K et al (2004)&#160;Pharmacokinetics of single dose intravenous propacetamol in neonates: effect of gestational age.&#160;Arch Dis Child: Fetal Neonatal Ed 89(1):F25&#8211;F28<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/fn.89.1.F25</pub-id><pub-id pub-id-type="pmcid">PMC1721651</pub-id><pub-id pub-id-type="pmid">14711849</pub-id></mixed-citation></ref><ref id="CR111"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jenkins</surname><given-names>C</given-names></name><name name-style="western"><surname>Costello</surname><given-names>J</given-names></name><name name-style="western"><surname>Hodge</surname><given-names>L</given-names></name></person-group><article-title>Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice</article-title><source>BMJ</source><year>2004</year><volume>328</volume><issue>7437</issue><fpage>434</fpage><pub-id pub-id-type="pmid">14976098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.328.7437.434</pub-id><pub-id pub-id-type="pmcid">PMC344260</pub-id></element-citation></ref><ref id="CR112"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Graham</surname><given-names>GG</given-names></name><name name-style="western"><surname>Scott</surname><given-names>KF</given-names></name><name name-style="western"><surname>Day</surname><given-names>RO</given-names></name></person-group><article-title>Tolerability of paracetamol</article-title><source>Drug Saf</source><year>2005</year><volume>28</volume><issue>3</issue><fpage>227</fpage><lpage>240</lpage><pub-id pub-id-type="pmid">15733027</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00002018-200528030-00004</pub-id></element-citation></ref><ref id="CR113"><label>113.</label><mixed-citation publication-type="other">Kashefi P, Mirdamadi M (2005)&#160;Preemptive analgesia with ibuprofen and acetaminophen in pediatric lower abdominal surgery. 10(4):5</mixed-citation></ref><ref id="CR114"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>White</surname><given-names>MC</given-names></name><name name-style="western"><surname>Nolan</surname><given-names>JA</given-names></name></person-group><article-title>An evaluation of pain and postoperative nausea and vomiting following the introduction of guidelines for tonsillectomy</article-title><source>Pediatr Anesth</source><year>2005</year><volume>15</volume><issue>8</issue><fpage>683</fpage><lpage>688</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1460-9592.2004.01516.x</pub-id><pub-id pub-id-type="pmid">16029404</pub-id></element-citation></ref><ref id="CR115"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Batton</surname><given-names>DG</given-names></name><name name-style="western"><surname>Barrington</surname><given-names>KJ</given-names></name><name name-style="western"><surname>Wallman</surname><given-names>C</given-names></name></person-group><article-title>Prevention and management of pain in the neonate: an update</article-title><source>Pediatrics</source><year>2006</year><volume>118</volume><issue>5</issue><fpage>2231</fpage><lpage>2241</lpage><pub-id pub-id-type="pmid">17079598</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.2006-2277</pub-id></element-citation></ref><ref id="CR116"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dart</surname><given-names>RC</given-names></name><etal/></person-group><article-title>Acetaminophen poisoning: an evidence-based consensus guideline for out-of-hospital management</article-title><source>Clin Toxicol (Phila)</source><year>2006</year><volume>44</volume><issue>1</issue><fpage>1</fpage><lpage>18</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/15563650500394571</pub-id><pub-id pub-id-type="pmid">16496488</pub-id></element-citation></ref><ref id="CR117"><label>117.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Lorin</surname><given-names>MI</given-names></name><etal/></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Feigin</surname><given-names>RD</given-names></name><etal/></person-group><article-title>Fever</article-title><source>Text book of pediatrics infectious disease</source><year>2004</year><publisher-loc>Philadelphia, PA</publisher-loc><publisher-name>Saunders</publisher-name><fpage>100</fpage><lpage>105</lpage></element-citation></ref><ref id="CR118"><label>118.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Keith</surname><given-names>RP</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Behrman</surname><given-names>RE</given-names></name><name name-style="western"><surname>Kliegman</surname><given-names>RM</given-names></name><name name-style="western"><surname>Jenson</surname><given-names>HB</given-names></name></person-group><article-title>Fever</article-title><source>Nelson Textbook of pediatrics</source><year>2007</year><publisher-loc>Philadelphia, PA</publisher-loc><publisher-name>WB Saunders</publisher-name><fpage>1084</fpage><lpage>1087</lpage></element-citation></ref><ref id="CR119"><label>119.</label><element-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Jenson</surname><given-names>HB</given-names></name><name name-style="western"><surname>Baltimore</surname><given-names>RS</given-names></name></person-group><person-group person-group-type="editor"><name name-style="western"><surname>Behrman</surname><given-names>RE</given-names></name><name name-style="western"><surname>Kliegman</surname><given-names>RM</given-names></name></person-group><article-title>Infectious disease</article-title><source>Nelson essential of pediatrics</source><year>2006</year><publisher-loc>Philadelphia</publisher-loc><publisher-name>Elsevier Saunders</publisher-name><fpage>446</fpage><lpage>450</lpage></element-citation></ref><ref id="CR120"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Karbasi</surname><given-names>SA</given-names></name><name name-style="western"><surname>Modares-Mosadegh</surname><given-names>M</given-names></name><name name-style="western"><surname>Golestan</surname><given-names>M</given-names></name></person-group><article-title>Comparison of antipyretic effectiveness of equal doses of rectal and oral acetaminophen in children</article-title><source>J Pediatr (Rio J)</source><year>2010</year><volume>86</volume><issue>3</issue><fpage>228</fpage><lpage>232</lpage><pub-id pub-id-type="pmid">20436978</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2223/JPED.1992</pub-id></element-citation></ref><ref id="CR121"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Amar</surname><given-names>P</given-names></name><name name-style="western"><surname>Schiff</surname><given-names>E</given-names></name></person-group><article-title>Acetaminophen safety and hepatotoxicity&#8212;where do we go from here?</article-title><source>Expert Opin Drug Saf</source><year>2007</year><volume>6</volume><fpage>341</fpage><lpage>355</lpage><pub-id pub-id-type="pmid">17688378</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1517/14740338.6.4.341</pub-id></element-citation></ref><ref id="CR122"><label>122.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gregoire</surname><given-names>N</given-names></name><etal/></person-group><article-title>Safety and pharmacokinetics of paracetamol following intravenous administration of 5 g during the first 24 h with a 2-g starting dose</article-title><source>Clin Pharmacol Ther</source><year>2007</year><volume>81</volume><issue>3</issue><fpage>401</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">17339870</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/sj.clpt.6100064</pub-id></element-citation></ref><ref id="CR123"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>H</given-names></name><etal/></person-group><article-title>Role of paracetamol in treatment of childhood fever: a double-blind randomized placebo controlled trial</article-title><source>Indian Pediatr</source><year>2007</year><volume>44</volume><issue>12</issue><fpage>903</fpage><lpage>911</lpage><pub-id pub-id-type="pmid">18175843</pub-id></element-citation></ref><ref id="CR124"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Korpela</surname><given-names>R</given-names></name><etal/></person-group><article-title>Oral naproxen but not oral paracetamol reduces the need for rescue analgesic after adenoidectomy in children</article-title><source>Acta Anaesthesiol Scand</source><year>2007</year><volume>51</volume><issue>6</issue><fpage>726</fpage><lpage>730</lpage><pub-id pub-id-type="pmid">17465970</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1399-6576.2007.01319.x</pub-id></element-citation></ref><ref id="CR125"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lewis</surname><given-names>DW</given-names></name><etal/></person-group><article-title>Efficacy of zolmitriptan nasal spray in adolescent migraine</article-title><source>Pediatrics</source><year>2007</year><volume>120</volume><issue>2</issue><fpage>390</fpage><lpage>396</lpage><pub-id pub-id-type="pmid">17671066</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1542/peds.2007-0085</pub-id></element-citation></ref><ref id="CR126"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Richardson</surname><given-names>M</given-names></name><etal/></person-group><article-title>Assessment and initial management of feverish illness in children younger than 5 years: summary of NICE guidance</article-title><source>BMJ (Clinical research ed)</source><year>2007</year><volume>334</volume><issue>7604</issue><fpage>1163</fpage><lpage>1164</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.39218.495255.AE</pub-id><pub-id pub-id-type="pmcid">PMC1885352</pub-id><pub-id pub-id-type="pmid">17540946</pub-id></element-citation></ref><ref id="CR127"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rose</surname><given-names>M</given-names></name></person-group><article-title>Systemic analgesics for children</article-title><source>Anaesthesia &amp; Intensive Care Medicine</source><year>2007</year><volume>8</volume><issue>5</issue><fpage>184</fpage><lpage>188</lpage></element-citation></ref><ref id="CR128"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Celebi</surname><given-names>S</given-names></name><etal/></person-group><article-title>Antipyretic effect of ketoprofen</article-title><source>The Indian Journal of Pediatrics</source><year>2009</year><volume>76</volume><fpage>287</fpage><lpage>291</lpage><pub-id pub-id-type="pmid">19129989</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12098-008-0234-z</pub-id></element-citation></ref><ref id="CR129"><label>129.</label><mixed-citation publication-type="other">van der Marel CD et al (2007)&#160;Rectal acetaminophen does not reduce morphine consumption after major surgery in young infants. BJA: British Journal of Anaesthesia 98(3):372&#8211;379<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bja/ael371</pub-id><pub-id pub-id-type="pmid">17284514</pub-id></mixed-citation></ref><ref id="CR130"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chiappini</surname><given-names>E</given-names></name><etal/></person-group><article-title>Management of fever in children: summary of the Italian Pediatric Society guidelines</article-title><source>Clin Ther</source><year>2009</year><volume>31</volume><issue>8</issue><fpage>1826</fpage><lpage>1843</lpage><pub-id pub-id-type="pmid">19808142</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clinthera.2009.08.006</pub-id></element-citation></ref><ref id="CR131"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hall</surname><given-names>RW</given-names></name><name name-style="western"><surname>Shbarou</surname><given-names>RM</given-names></name></person-group><article-title>Drugs of choice for sedation and analgesia in the neonatal ICU</article-title><source>Clin Perinatol</source><year>2009</year><volume>36</volume><issue>1</issue><fpage>15</fpage><lpage>26</lpage><pub-id pub-id-type="pmid">19161862</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clp.2008.09.007</pub-id><pub-id pub-id-type="pmcid">PMC2662993</pub-id></element-citation></ref><ref id="CR132"><label>132.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oscier</surname><given-names>CD</given-names></name><name name-style="western"><surname>Milner</surname><given-names>QJ</given-names></name></person-group><article-title>Peri-operative use of paracetamol</article-title><source>Anaesthesia</source><year>2009</year><volume>64</volume><issue>1</issue><fpage>65</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">19087009</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2044.2008.05674.x</pub-id></element-citation></ref><ref id="CR133"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Southey</surname><given-names>ER</given-names></name><name name-style="western"><surname>Soares-Weiser</surname><given-names>K</given-names></name><name name-style="western"><surname>Kleijnen</surname><given-names>J</given-names></name></person-group><article-title>Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever</article-title><source>Curr Med Res Opin</source><year>2009</year><volume>25</volume><issue>9</issue><fpage>2207</fpage><lpage>2222</lpage><pub-id pub-id-type="pmid">19606950</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1185/03007990903116255</pub-id></element-citation></ref><ref id="CR134"><label>134.</label><mixed-citation publication-type="other">Wilson-Smith EM, Morton NS (2009) Survey of i.v. paracetamol (acetaminophen) use in neonates and infants under 1 year of age by UK anesthetists. Paediatr Anaesth&#160;19(4):329&#8211;37<pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1460-9592.2009.02947.x</pub-id><pub-id pub-id-type="pmid">19335345</pub-id></mixed-citation></ref><ref id="CR135"><label>135.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Allegaert</surname><given-names>K</given-names></name><name name-style="western"><surname>Naulaers</surname><given-names>G</given-names></name></person-group><article-title>Haemodynamics of intravenous paracetamol in neonates</article-title><source>Eur J Clin Pharmacol</source><year>2010</year><volume>66</volume><issue>9</issue><fpage>855</fpage><lpage>858</lpage><pub-id pub-id-type="pmid">20607221</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00228-010-0860-z</pub-id></element-citation></ref><ref id="CR136"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elvir-Lazo</surname><given-names>OL</given-names></name><name name-style="western"><surname>White</surname><given-names>PF</given-names></name></person-group><article-title>The role of multimodal analgesia in pain management after ambulatory surgery</article-title><source>Curr Opin Anaesthesiol</source><year>2010</year><volume>23</volume><issue>6</issue><fpage>697</fpage><lpage>703</lpage><pub-id pub-id-type="pmid">20847690</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ACO.0b013e32833fad0a</pub-id></element-citation></ref><ref id="CR137"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pierce</surname><given-names>CA</given-names></name><name name-style="western"><surname>Voss</surname><given-names>B</given-names></name></person-group><article-title>Efficacy and safety of ibuprofen and acetaminophen in children and adults: a meta-analysis and qualitative review</article-title><source>Ann Pharmacother</source><year>2010</year><volume>44</volume><issue>3</issue><fpage>489</fpage><lpage>506</lpage><pub-id pub-id-type="pmid">20150507</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1345/aph.1M332</pub-id></element-citation></ref><ref id="CR138"><label>138.</label><mixed-citation publication-type="other">Kett DH et al (2011) A randomized study of the efficacy and safety of intravenous acetaminophen vs. intravenous placebo for the treatment of fever. Clin Pharmacol Ther&#160;90(1):32&#8211;9<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/clpt.2011.98</pub-id><pub-id pub-id-type="pmid">21544074</pub-id></mixed-citation></ref><ref id="CR139"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Macario</surname><given-names>A</given-names></name><name name-style="western"><surname>Royal</surname><given-names>MA</given-names></name></person-group><article-title>A literature review of randomized clinical trials of intravenous acetaminophen (paracetamol) for acute postoperative pain</article-title><source>Pain Pract</source><year>2011</year><volume>11</volume><issue>3</issue><fpage>290</fpage><lpage>296</lpage><pub-id pub-id-type="pmid">21114616</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1533-2500.2010.00426.x</pub-id></element-citation></ref><ref id="CR140"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ji</surname><given-names>P</given-names></name><etal/></person-group><article-title>Regulatory review of acetaminophen clinical pharmacology in young pediatric patients</article-title><source>J Pharm Sci</source><year>2012</year><volume>101</volume><issue>12</issue><fpage>4383</fpage><lpage>4389</lpage><pub-id pub-id-type="pmid">23073837</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jps.23331</pub-id></element-citation></ref><ref id="CR141"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oncel</surname><given-names>MY</given-names></name><etal/></person-group><article-title>Intravenous paracetamol treatment in the management of patent ductus arteriosus in extremely low birth weight infants</article-title><source>Neonatology</source><year>2013</year><volume>103</volume><issue>3</issue><fpage>166</fpage><lpage>169</lpage><pub-id pub-id-type="pmid">23258386</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000345337</pub-id></element-citation></ref><ref id="CR142"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Engstr&#246;m Ruud</surname><given-names>L</given-names></name><etal/></person-group><article-title>Acetaminophen reduces lipopolysaccharide-induced fever by inhibiting cyclooxygenase-2</article-title><source>Neuropharmacology</source><year>2013</year><volume>71</volume><fpage>124</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">23545161</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.neuropharm.2013.03.012</pub-id></element-citation></ref><ref id="CR143"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Heard</surname><given-names>K</given-names></name><etal/></person-group><article-title>Toxicity from repeated doses of acetaminophen in children: assessment of causality and dose in reported cases</article-title><source>Am J Ther</source><year>2014</year><volume>21</volume><issue>3</issue><fpage>174</fpage><lpage>183</lpage><pub-id pub-id-type="pmid">22407198</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MJT.0b013e3182459c53</pub-id><pub-id pub-id-type="pmcid">PMC3374904</pub-id></element-citation></ref><ref id="CR144"><label>144.</label><mixed-citation publication-type="other">Rumack BH (1984)&#160;Acetaminophen overdose in young children. Treatment and effects of alcohol and other additional ingestants in 417 cases. Am J Dis Child&#160;138(5):428&#8211;33<pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/archpedi.1984.02140430006003</pub-id><pub-id pub-id-type="pmid">6711498</pub-id></mixed-citation></ref><ref id="CR145"><label>145.</label><mixed-citation publication-type="other">al-Obaidy SS et al (1996) Metabolism of paracetamol in children with chronic liver disease. Eur J Clin Pharmacol&#160;50(1&#8211;2):69&#8211;76<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s002280050071</pub-id><pub-id pub-id-type="pmid">8739814</pub-id></mixed-citation></ref><ref id="CR146"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ragg</surname><given-names>P</given-names></name><name name-style="western"><surname>Davidson</surname><given-names>A</given-names></name></person-group><article-title>Comparison of the efficacy of paracetamol versus paracetamol, codeine and promethazine (Painstop) for premedication and analgesia for myringotomy in children</article-title><source>Anaesth Intensive Care</source><year>1997</year><volume>25</volume><issue>1</issue><fpage>29</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">9075510</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0310057X9702500105</pub-id></element-citation></ref><ref id="CR147"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anderson</surname><given-names>BJ</given-names></name><name name-style="western"><surname>Woollard</surname><given-names>GA</given-names></name><name name-style="western"><surname>Holford</surname><given-names>NH</given-names></name></person-group><article-title>Acetaminophen analgesia in children: placebo effect and pain resolution after tonsillectomy</article-title><source>Eur J Clin Pharmacol</source><year>2001</year><volume>57</volume><issue>8</issue><fpage>559</fpage><lpage>569</lpage><pub-id pub-id-type="pmid">11758634</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s002280100367</pub-id></element-citation></ref><ref id="CR148"><label>148.</label><mixed-citation publication-type="other">James LP et al (2001)&#160;Evaluation of occult acetaminophen hepatotoxicity in hospitalized children receiving acetaminophen. Pediatric Pharmacology Research Unit Network. Clin Pediatr (Phila)&#160;40(5):243&#8211;8<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/000992280104000501</pub-id><pub-id pub-id-type="pmid">11388672</pub-id></mixed-citation></ref><ref id="CR149"><label>149.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wong</surname><given-names>A</given-names></name><etal/></person-group><article-title>Antipyretic effects of dipyrone versus ibuprofen versus acetaminophen in children: results of a multinational, randomized, modified double-blind study</article-title><source>Clin Pediatr (Phila)</source><year>2001</year><volume>40</volume><issue>6</issue><fpage>313</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">11824173</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/000992280104000602</pub-id></element-citation></ref><ref id="CR150"><label>150.</label><mixed-citation publication-type="other">Messeri A et al (2003)&#160;Analgesic efficacy and tolerability of ketoprofen lysine salt vs paracetamol in common paediatric surgery. A randomized, single-blind, parallel, multicentre trial. Paediatr Anaesth&#160;13(7):574&#8211;8<pub-id pub-id-type="doi" assigning-authority="pmc">10.1046/j.1460-9592.2003.01089.x</pub-id><pub-id pub-id-type="pmid">12950856</pub-id></mixed-citation></ref><ref id="CR151"><label>151.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kramer</surname><given-names>LC</given-names></name><etal/></person-group><article-title>Alternating antipyretics: antipyretic efficacy of acetaminophen versus acetaminophen alternated with ibuprofen in children</article-title><source>Clin Pediatr (Phila)</source><year>2008</year><volume>47</volume><issue>9</issue><fpage>907</fpage><lpage>911</lpage><pub-id pub-id-type="pmid">18539869</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/0009922808319967</pub-id></element-citation></ref><ref id="CR152"><label>152.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ruperto</surname><given-names>N</given-names></name><etal/></person-group><article-title>A randomized, double-blind, placebo-controlled trial of paracetamol and ketoprofren lysine salt for pain control in children with pharyngotonsillitis cared by family pediatricians</article-title><source>Ital J Pediatr</source><year>2011</year><volume>37</volume><fpage>48</fpage><pub-id pub-id-type="pmid">21958958</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1824-7288-37-48</pub-id><pub-id pub-id-type="pmcid">PMC3192740</pub-id></element-citation></ref><ref id="CR153"><label>153.</label><mixed-citation publication-type="other">Dang D et al (2013) Comparison of oral paracetamol versus ibuprofen in premature infants with patent ductus arteriosus: a randomized controlled trial. PLoS One&#160;8(11):e77888<pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0077888</pub-id><pub-id pub-id-type="pmcid">PMC3817181</pub-id><pub-id pub-id-type="pmid">24223740</pub-id></mixed-citation></ref><ref id="CR154"><label>154.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kessel</surname><given-names>I</given-names></name><etal/></person-group><article-title>Paracetamol effectiveness, safety and blood level monitoring during patent ductus arteriosus closure: a case series</article-title><source>J Matern Fetal Neonatal Med</source><year>2014</year><volume>27</volume><issue>16</issue><fpage>1719</fpage><lpage>1721</lpage><pub-id pub-id-type="pmid">24460433</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/14767058.2013.871630</pub-id></element-citation></ref><ref id="CR155"><label>155.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Terrin</surname><given-names>G</given-names></name><etal/></person-group><article-title>Efficacy of paracetamol for the treatment of patent ductus arteriosus in preterm neonates</article-title><source>Ital J Pediatr</source><year>2014</year><volume>40</volume><issue>1</issue><fpage>21</fpage><pub-id pub-id-type="pmid">24555510</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1824-7288-40-21</pub-id><pub-id pub-id-type="pmcid">PMC3940001</pub-id></element-citation></ref><ref id="CR156"><label>156.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dash</surname><given-names>SK</given-names></name><etal/></person-group><article-title>Enteral paracetamol or intravenous indomethacin for closure of patent ductus arteriosus in preterm neonates: a randomized controlled trial</article-title><source>Indian Pediatr</source><year>2015</year><volume>52</volume><issue>7</issue><fpage>573</fpage><lpage>578</lpage><pub-id pub-id-type="pmid">26244949</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s13312-015-0677-z</pub-id></element-citation></ref><ref id="CR157"><label>157.</label><mixed-citation publication-type="other">Bagheri MM et al (2016)&#160;Comparison of oral acetaminophen versus ibuprofen in premature infants with patent ductus arteriosus. Iran J Pediatr&#160;26(4):e3975<pub-id pub-id-type="doi" assigning-authority="pmc">10.5812/ijp.3975</pub-id><pub-id pub-id-type="pmcid">PMC5045561</pub-id><pub-id pub-id-type="pmid">27713809</pub-id></mixed-citation></ref><ref id="CR158"><label>158.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Memisoglu</surname><given-names>A</given-names></name><etal/></person-group><article-title>Ductal closure with intravenous paracetamol: a new approach to patent ductus arteriosus treatment</article-title><source>J Matern Fetal Neonatal Med</source><year>2016</year><volume>29</volume><issue>6</issue><fpage>987</fpage><lpage>990</lpage><pub-id pub-id-type="pmid">25781500</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3109/14767058.2015.1029912</pub-id></element-citation></ref><ref id="CR159"><label>159.</label><mixed-citation publication-type="other">Cranswick N, Coghlan D (2000)&#160;Paracetamol efficacy and safety in children: the first 40 years. Am J Ther 7:135&#8211;142<pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00045391-200007020-00010</pub-id><pub-id pub-id-type="pmid">11319581</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>